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ABSTRACT OF THE DISSERTATION
Exploring β-cell function and heterogeneity in obese SM/J mice
by
Mario Miranda
Doctor of Philosophy in Biology and Biomedical Sciences
Developmental, Regenerative, and Stem Cell Biology
Washington University in St. Louis, 2021
Heather A. Lawson, Chair

Pancreatic β-cells perform glucose-stimulated insulin secretion, a process required to
maintain systemic glucose homeostasis. Obesity promotes glycemic and inflammatory stress,
causing β-cell death and dysfunction, resulting in diabetes. Efforts to improve β-cell function in
obesity have been hampered by observations that β-cells are highly heterogeneous, varying in
morphology, function, and gene expression. There is great need to understand the breadth of βcell heterogeneity in health and obesity to improve diabetic therapies.
High fat-fed SM/J mice spontaneously transition from hyperglycemic-obese to
normoglycemic-obese with age, providing a unique opportunity to study β-cell adaptation. Here,
we show that as they resolve hyperglycemia, obese SM/J mice dramatically increase circulating
and pancreatic insulin levels while improving insulin sensitivity. Immunostaining of pancreatic
sections reveals that obese SM/J mice selectively increase β-cell mass but not α-cell mass.
Functional assessment of isolated islets reveals that obese SM/J mice increase glucose stimulated
insulin secretion, decrease basal insulin secretion, and increase islet insulin content. Next, we
integrate pancreatic islet single cell and bulk RNA sequencing data to identify β-cell
vii

subpopulations based on gene expression and characterize genetic networks associated with βcell function in obese SM/J mice.

We assign roles to 4 β-cell subpopulations, whose

composition is influenced by age, sex, and diet. Network analysis identified fatty acid
metabolism and β-cell physiology gene expression modules associated with the hyperglycemicobese state. We identify subtype-specific expression of Pdyn and Fam151a as candidate
regulators of β-cell function in obesity. These results establish that improved β-cell function
underlies the resolution of hyperglycemia, which may be driven by changes in subpopulation
structure and decreased fatty acid metabolism.
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Chapter 1: Introduction

By
Mario A Miranda, Juan F Macias-Velasco, Heather A Lawson

Adapted for dissertation from the published manuscript:
Miranda MA, Macias-Velasco JF, Lawson HA. Pancreatic β-cell heterogeneity in health and
diabetes: Classes, Sources, and Subtypes. American Journal of Physiology - Endocrinology and
Metabolism. 2021 Apr 1;320(4):E716-E731. PMID: 33586491
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1.1 Overview
Pancreatic β-cells perform glucose-stimulated insulin secretion, a process at the center of type 2
diabetes etiology. Efforts to understand how β-cells behave in healthy and stressful conditions
have revealed a wide degree of morphological, functional, and transcriptional heterogeneity.
Sources of heterogeneity include β-cell topography, developmental origin, maturation state, and
stress response. Advances in sequencing and imaging technologies have led to the identification
of β-cell subtypes, which play distinct roles in the islet niche. This chapter reviews β-cell
heterogeneity from morphological, functional, and transcriptional perspectives, and considers the
relevance of topology, maturation, development, and stress response. It also discusses how these
factors have been used to identify β-cell subtypes, and how heterogeneity is impacted by
diabetes. We examine open questions in the field and discuss recent technological innovations
that could advance understanding of β-cell heterogeneity in health and disease.
1.2 Heterogeneity in β-cells, a need for greater understanding
Pancreatic islet β-cells are optimized to secrete insulin, a process critical for maintaining
appropriate blood glucose concentration. This requires coordination of glucose sensing and
metabolism, ATP production via oxidative phosphorylation, insulin biosynthesis, and [Ca2+]dependent insulin release1. In type 2 diabetes, peripheral insulin resistance promotes initial β-cell
expansion, but ultimately results in β-cell death and dysfunction2–4. Therapies include
Metformin, sulfonylureas, and injection of exogenous insulin, which do not improve long-term
β-cell function, and have been associated with weight gain, cancer, and hypoglycemic events5–7.
Current research strategies include ameliorating disrupted β-cell signaling pathways, removing
dysfunctional β-cells, and improving the β-cell microenvironment8–12. Triggering β-cell
2

neogenesis, transdifferentiation of other cell types, and inducing β-cell replication are also being
explored13–16. Many of the therapeutic agents that improve β-cell function are in various stages of
development17. These strategies require understanding the physiological mechanisms controlling
β-cell function and are complicated by observations that not all β-cells are alike.
Cell sorting, imaging, and sequencing technologies have allowed for analysis of multiple
β-cell properties, revealing that β-cells vary in morphology, function, and gene expression.
Drivers of heterogeneity include β-cell topography, developmental origin, maturation state, and
stress respons18–21. Several groups have proposed that distinct β-cell subtypes exist, and play
unique roles within the islet22–25. The importance of heterogeneity is reinforced by observations
that β-cells are subject to variable fates in diabetes including apoptosis, replication, and
dedifferentiation2,26–28. Characterization of β-cell heterogeneity has led to questions about its role
in diabetic etiology and therapy29. This review examines current understanding of the breadth
and sources of β-cell heterogeneity and its relevance to diabetes. Examining heterogeneity lends
itself to questions about the applications and limitations of β-cell plasticity, which can focus
research aimed at improving β-cell function.
1.3 β-cells are morphologically and functionally heterogeneous
Histological assessment of the pancreatic islets show β-cells vary in basic morphology,
including larger cells with large nuclei that localize near the islet center30,31. Increased nuclear
size is attributed to polyploidy; β-cells are the only endocrine cell type observed in tetra- and
octoploid states32. The cause of polyploidy in β-cells is linked to metabolic stress, as mean
nuclear size and incidence of polyploidy increase in diabetes32–35. β-cells exhibit morphological
variation in other organelles, with central β-cells exhibiting enlarged endoplasmic reticulum (ER)
3

and Golgi apparatuses following short glucose exposure36. Other features that distinguish central
from peripheral β-cells include mitochondrial morphology, number of insulin granules, and
number of cell-cell contacts34,37–40. Most β-cells exhibit polarity, consisting of an apical face
where primary cilia project into extracellular space, a lateral face where glucose uptake and
insulin secretion occur, and a basal face connected to vasculature, forming a rosette-like structure
around capillaries41–44. Further, β-cells with atypical cellular organization have also been
identified, including nonpolar cells and cells with apical mRNA localization23,45. β-cells display
observable cell cycle variability, with <0.5% of adult human β-cells and 2% of adult mouse βcells displaying markers of mitosis46,47. This replication rate is increased in obesity, pregnancy,
and with glucocorticoids48–51. Clearly, β-cells vary in basic cellular features, and experiments
reveal that β-cell function is equally diverse.
Glucose-stimulated insulin secretion has been characterized in depth52–55. Glucose is
converted to pyruvate through glycolysis initiated by glucokinase (Gck), then promotes ATP
production through the Citric Acid Cycle and oxidative phosphorylation, which triggers
membrane depolarization and [Ca2+]-dependent insulin release. Fluorescence-activated cell
sorting (FACS) based on metabolic activity of individual β-cells using NADPH autofluorescence
revealed 25% of rat β-cells do not increase activity in high (20mM) glucose conditions56. A
follow-up study examined metabolic responders and non-responders at 7.5mM glucose57.
Responders enter first phase insulin secretion at lower glucose concentration and secrete more
insulin, despite having similar insulin stores. This is attributed to preferential secretion of newly
synthesized insulin over stored insulin and is supported by work showing insulin biosynthesis is
stimulated by glucose and that responsive cells are enriched for proinsulin-rich granules58,59.
4

Thus, glucose sensitive cells produce and release mature insulin granules rapidly, resulting in
elevated proinsulin/insulin ratio. Dispersed human β-cells display variation in insulin secretion,
with 20% of cells secreting 70-90% of insulin60,61. Sorting β-cells based on metabolic activity at
16.7 mM glucose revealed metabolically responsive β-cells are larger in size62. Controlling for
cell size shows metabolically active and inactive cells secrete similar amounts of insulin. Thus,
insulin secretion is influenced by cell size, linking β-cell morphology and insulin secretion. This
evidence was corroborated by observations that larger, central β-cells degranulate faster than
peripheral cells in vivo in response to hyperglycemic conditions36. Observations that insulin
secretion varies between β-cells has been confirmed by a variety of techniques including patchclamp measurements and 3D imaging63–65.
Glucose sensitivity is associated with higher expression of glycolytic and protein
biosynthesis genes and correlates with the glucose phosphorylation activity of Gck66,67.
Treatment with glyceraldehyde bypasses glucose phosphorylation to induce metabolic activity in
glucose-unresponsive cells at low glucose concentrations but cannot exceed maximum glucoseinduced insulin biosynthesis, suggesting Gck activity is the rate limiting step in insulin synthesis
and secretion68. Giordano et al. assessed the stability of glucose sensitivity during repeat glucose
exposure using a hemolytic plaque technique to measure insulin secretion69. They found 75% of
β-cells were consistently responsive or unresponsive following 3 glucose exposures, while 25%
of β-cells switched between states, suggesting glucose sensitivity fluctuates in a subset of cells.
Glucose sensitivity is predictive of susceptibility to mitotic stimuli and protection against
oxidative damage and apoptosis, hinting at how cells would fare in diabetes51,56,70. Collectively,
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these observations highlight the breadth of phenotypic variation in β-cells, motivating studies
aimed at understanding the mechanisms underlying these differences.
1.4 Heterogeneity in gene and protein expression
Many genes in the insulin secretion pathway display heterogeneous expression and have
a direct impact on β-cell function. Glucose import through Glut2 is the first step in the insulin
secretion pathway and is inhibited in STZ-induced diabetes in mice71. Heterogeneous Glut2
expression has been reported in several studies and may be indicative of maturation state and
replicative potential25,45,72–76. The rate-limiting enzyme Gck is variably expressed among β-cells,
correlating with glucose sensitivity, Glut2 levels, and number of insulin granules67,77. Metabolic
perturbations influence Gck expression, which precede changes in Ins2 expression, suggesting a
regulatory role in insulin production78. Variation in insulin gene expression and protein levels
has been observed in many studies23,38,74,78,79. Central β-cells contain less insulin protein than
peripheral β-cells, a distinction that disappears with fasting78. Using an insulin promoter
construct linked with GFP, Katsuta et al. used FACS to separate β-cells containing low, medium,
and high levels of insulin protein38. Medium level β-cells comprised 70% of cells, and the low
insulin population had diminished insulin gene expression and secretion. Variable expression of
these components may directly contribute to the heterogeneity seen at the phenotypic level.
Other gene markers of β-cell heterogeneity with a less direct connection to insulin
secretion have been identified. These include cell-cell adhesion genes like the sialylated form of
neural cell adhesion molecule (PSA-NCAM)80. FACs sorting β-cells into PSA-NCAM-high and
-low populations revealed that expression correlates with glucose-stimulated insulin
secretion73,81,82. PSA-NCAM-low cells have less Ca2+ influx following glucose exposure,
6

reduced ATP levels, and decreased expression of Glut2 and Gck. Morphologically, PSA-NCAM
knockout cells differ in f-actin distribution, altering cell polarity80. The proportion of PSANCAM-high cells increases in diabetes73. Whether NCAM is heterogeneously expressed in
humans is unknown. β-cells can be sorted based on expression of E-cadherin, which promotes
islet formation and compaction83–85. Like NCAM, sorting β-cells into E-cadherin-high and-low
populations revealed that higher expression is associated with increased glucose-stimulated
insulin secretion and insulin expression83. Further, glucose induces E-cadherin expression and
causes dispersed β-cells to aggregate in vitro84. Other variably expressed genes include Npy, Th,
Vmat2, and Dickkopf-386–89.
Several studies have identified β-cell subpopulations based on variation in global gene
expression. Baron et al. found two subpopulations in nondiabetic donors driven by variable
expression of ER-stress response genes including HERPUD1, HSPA5 and DDIT3, which
correspond with low expression of genes associated with β-cell function including UCN3,
MAFA, and NEUROD190. This heterogeneity was lost in hyperglycemic samples. Similarly,
Muraro et al. identified 3 β-cell populations, one of which had elevated expression of stress
response genes HERPUD1 and HSPA1B91. Importantly, Muraro et al. validated these findings
using RNA-FISH on intact islets to rule out isolation-induced stress. Xin et al. identified four
subpopulations in human β-cells, one of which differentially expressed 431 genes21. This
subpopulation had low insulin expression and elevated expression of ER-stress and UPRassociated genes. Fang et al. profiled 9,964 β-cells from healthy and diabetic donors and
identified a subpopulation enriched for expression of heat shock proteins92. Lastly, Segerstolpe et
al. identified 5 subgroups based on expression of RBP4, FFAR/GPR120, and ID family
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transcription factors93. RBP4 expression is associated with insulin resistance, while ID
transcription factors are associated with cell cycle activity94,95. Several groups have failed to
detect β-cell subpopulations; however, many were limited by the number of β-cells analyzed96–
101

. Despite little consensus in the genes that may drive heterogeneity, an emerging pattern

suggests β-cells differ in expression of genes related to stress response.
The limitations of single cell technology explain some of the discordance among studies.
These shortcomings are highlighted in a meta-analysis from Mawla and Huising, who examined
discrepancies across five single cell RNA sequencing studies90,91,93,97,99,102. Pooling β-cells across
all studies revealed 2 populations of β-cells driven by differential expression of 52 genes. These
include genes associated with other endocrine and exocrine cell types, but not stress response.
Only 3 genes had previously been associated with β-cell heterogeneity: RBP4, DLK1, and
HERPUD1. When subset into cells from healthy donors, only 24 genes were differentially
expressed across β-cells. Among these, only NPY has been previously associated with β-cell
heterogeneity. This lack of correspondence among studies is a concern. Only 86 genes were
detected in all β-cells within the aggregated data. This contrasts with the hundreds of
housekeeping genes required for cellular function103. β-cells express at least 18,000 genes, thus
99.5% of genes are inconsistently captured21,93. With current methodology, the capture of most
genes is likely due to technical artifacts or random chance, and not intrinsic biological
variation104. Methods for preprocessing and noise removal are being developed to aid in quality
control, including tools that remove cell doublets, remove ambient RNA, assess transcript
coverage, and provide imputation for gene dropout105–108. In human studies, donor age and
isolation procedure likely contribute to discordance among studies but are seldom controlled for.
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Further, many groups report differential expression of genes between subsets of β-cells, but
effect size is rarely reported or discussed. As technological advances increase single cell
sequencing read depth, profiling of thousands of cells all but guarantees statistically significant
differential expression based on p-values alone. Discussions about whether these differences are
meaningful will be increasingly important, and will be aided by measuring effect size109.
Dorrell et al. used FACS to identify 4 subpopulations based on expression of human βcell surface markers CD9 and ST8SIA1110. They designated these populations as β1–4, where
β1/ β2 cells are positive for ST8SIA1 and β3/β4 are ST8SIA1 negative. There are 125 genes
differentially expressed across groups, while gene ontology enrichment analysis revealed β1/β2
cells are enriched for protein secretion, while β3/β4 cells are enriched for neurogenesis. This
corresponds with β1/β2 populations having greater glucose-stimulated insulin secretion, while
β3/β4 have elevated basal insulin secretion. The proportions of these populations are altered in
diabetic individuals, suggesting they differ in susceptibility to metabolic stress, with the caveat
that inter-patient variation is much higher than variation between healthy and diabetic donors.
How these markers of heterogeneity are tied to β-cell function remain areas of interest. It is
possible that these populations have separate roles within the islet niche, with β1/β2 cells
specializing in glucose-stimulated insulin secretion, and β3/β4 cells specializing in basal insulin
secretion.
The potential existence of specialized basal insulin secreting β-cells is supported by
Farack et al., who used smFISH to identify a subpopulation of mouse β-cells with elevated
insulin expression23. These cells, termed “extreme” β-cells, represent ~7% of β-cells, and
localize near the islet center. Extreme β-cells have a distinct polarization pattern, high pro-insulin
9

and ribosomal RNA content, and less mature insulin protein. They have elevated expression of
Ins1, Iapp, Chga, and Pcsk2 which are associated with insulin secretion. Thus, the authors
suggest that these cells are producing and quickly secreting high levels of insulin, so they
maintain a high proinsulin/insulin ratio despite having other markers of β-cell maturity. The
proportion of extreme β-cells increase in db/db mice, suggesting they may play a role in
glycemic stress response. These findings are summarized in Figure 1.1. Could these extreme βcells overlap with the β3 and β4 populations identified by Dorrell et al.110? Or with PSA-NCAMlow and E-cadherin-low cell populations? Answers to these questions may provide insight into
how to remedy the dysregulated glucose-stimulated insulin secretion seen in diabetic islets.
Discussed below are 4 factors that influence β-cell behavior: topology, development, maturation,
and stress response. These factors provide insight into how β-cell heterogeneity is maintained,
and how it may be harnessed for therapeutic purposes.
1.5 Topography influences β-cell heterogeneity
In addition to β-cells, islets contain α-cells, 𝛿-cells, ε-cells, γ-cells, as well as nonendocrine cells including endothelial cells, macrophages, glia, fibroblasts, and pericytes61,111.
Mice and humans have different islet compositions, which may explain why few discoveries
from rodents validate in humans42,61,112,113. Mouse islets are comprised of 60-80% β-cells and 1520% α-cells. β-cells localize to the center, or core, of the islet, while α- and 𝛿-cells localize to the
periphery, or mantle. Human islets are comprised of 50% β-cells and 40% α-cells. Recent
imaging efforts suggest human islets comprise small repeating clusters of the β-cell core, α-cell
mantle pattern42,113,114. Further, location within the pancreas influences islet cell composition.
Islets in the pancreatic head are enriched for γ-cells, while islets enriched in α-cells are found in
10

the neck. The proportion of β-cells per islet increases from head to tail of pancreas115–117. Islets in
the tail of the pancreas degranulate faster than head islets in vivo following prolonged glucose
exposure, and have higher rates of replication, insulin synthesis, and secretion36,118–120. Human
islets near the pancreatic head tend to be less spherical than those found in the tail, which may
influence cell-cell communication121. NCAM plays a role in islet organization, as NCAM
knockout mice have altered islet cell composition, including α-cell infiltration into the islet
core80. Both humans and mice display altered islet composition in diabetes, including deviation
from the mantle-core arrangement122,123. β-cell loss is more pronounced in γ-cell-rich islets
within the head of the pancreas in diabetes120. β-cells in the splenic region of the pancreas
undergo proliferation during diabetes, while those near the head do not56.
As previously discussed, β-cells near the islet core exhibit morphological and functional
differences from those in the periphery31,36,78,124–126. These differences are attributed to the homoand heterotypic connections maintained by each cell, a result of the mantle-core architecture of
the islet, in which core β-cells are enriched for homotypic contacts127. Dispersed β-cells secrete
less insulin in response to glucose than β-cells in an intact islet128,129. β-cells coupled with other
β-cells secrete more insulin than individual β-cells, while β-α-cell couplings produce more
insulin than individual β-cells, but less than β-β-cell coupling60,129,130. Peripheral β-cells have
more heterotypic contacts with somatostatin-secreting 𝛿-cells, which inhibits insulin
secretion124,131–134. Importantly, comparisons between core and peripheral β-cells in islets
cultured ex vivo are confounded by the rapid onset of hypoxia in the islet core following
isolation, particularly in large islets135–137. It is critical that observations comparing each
population are verified using complementary methods. Primary cilia influence β-cell function by
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facilitating communication with neighboring cells, and further exploration is needed to see if
they play a role in maintaining heterogeneity138,139. The morphological and functional differences
between core and peripheral β-cells may be derived from connections to other β-cells, α-cells, or
𝛿-cells, which in turn is influenced by the location of the islet within the pancreas (summarized
in Figure 1.1C).
Within each islet, small clusters of β-cells synchronize Ca2+ fluctuations140. This is
attributed to gap junctions between β-cells coordinating insulin release and may explain why
coupled cells secrete more insulin than isolated cells39,124,141,142. Gap junctions are
heterogeneously expressed across the population39,40,141,143. A subpopulation of hyperconnected
β-cells has been proposed24. These “hub” cells were identified by quantifying the number of
significant pairwise correlations of glucose-stimulated Ca2+ oscillations that each cell
maintained. These cells represent 1-10% of all β-cells and control the activity of “follower” cells
by coordinating Ca2+ signaling through gap junctions. These cells express high levels of Gck and
genes involved in glucose oxidation, but low levels of insulin, and have accelerated and extended
Ca2+ signaling during glucose stimulation. Ablation of hub cells disrupts Ca2+ synchronization
across the islet, while ablating follower cells had no effect. These cells are sensitive to diabetic
insults, which could explain why Ca2+ coordinated insulin release is disrupted in diabetes. These
findings are summarized in Figure 1.1E. Salem et al. built upon this model, showing
transplanted islets contain hyperconnected β-cells, termed “leader” cells, that trigger a wave of
calcium release across the islet

144

. The role of hub/leader cells have been challenged, because

the mechanisms through which hyperpolarizing hub cells inhibit Ca2+ coordination among other
cells is unclear145. The relevance of such a subpopulation has been questioned, as disrupting Ca2+
12

signaling in ~70% of β-cells does not alter insulin secretion, suggesting other mechanisms are of
greater importance146–148. Further, knockout of the gap junction protein Cx36 in mice results in
altered calcium synchronization, but has minimal effect on overall insulin release, suggesting
Ca2+ signaling is influential but not critical for β-cell function149,150.
Vascularization and innervation also vary amongst islets and provide a template for
heterogeneity. Capillaries provide nutrients, oxygen, and ECM support to islets, which improve
insulin secretion and promote cell survival151–153. Small islets have 2-3 vascular penetrations,
large islets have >3, resulting in β-cells receiving unequal access153. Islets in the pancreatic
periphery receive capillary branches, while islets at the center directly contact large blood
vessels153. Several groups have proposed the existence of two classes of islets based on
vascularization, high-perfused and low-perfused154–156. High-perfused populations represent 75%
of islets, have higher glucose-stimulated insulin secretion and greater rates of β-cell replication,
but are susceptible to cytokine induced cell death and hypoxia154–156. These differences are
attributed to capillaries increasing oxygen tension within β-cells155. The low-perfused islets
appear to serve as reserves and are recruited to activity when metabolic demand increases154,155.
β-cells organize themselves around capillaries in rosette structures, with insulin granules
localizing towards the capillary and driving polarity41,42. Evidence suggests blood typically flows
from islet core to mantle, from β-cells, to α-cells, then 𝛿-cells153,157–159. This may bias
directionality of cell-cell communication among endocrine cells159,160. Innervation also impacts
islet development, maturation, mass, and function161–163. While only a small number of β-cells
receive axon terminals, which tend to reside in the islet periphery, neurotransmitters including
serotonin and GABA promote β-cell replication164–167. Human islets have less innervation than
13

mouse islets, which may explain why they have lower regenerative capacity168. However, it is
unclear if differences in biological age between mice and human donors confound these findings.
Clearly the location of the β-cell within the islet, and the islet within the pancreas, influences βcell exposure to nutrients and potentially harmful milieu. As β-cell heterogeneity is explored in
greater depth, topology may aid in understanding why cells behave differently.
1.6 Developmental origin influences β-cell heterogeneity
The pancreas arises from two epithelial evaginations in the foregut, termed the dorsal and
ventral buds, which give rise to the head and tail regions, respectively169. Despite differences in
blood supply and innervation, both buds contain endocrine progenitor-precursor cells, which
give rise to nascent β-cells169–172. Using chimeric mice, Deltour et al. showed that individual
islets contain β-cells with different developmental origins, suggesting β-cells are not monoclonal
within the islet173. Nascent β-cells undergo an initial period of replication, peaking at 20 weeks
gestation174. β-cell replication remains high at birth, then declines rapidly with age, resulting in a
several-fold expansion of β-cell mass between birth and adulthood175. β-cell telomere length
diminishes over time, particularly during the first two months of life, when β-cell proliferation is
at its highest176. Further, 4-month-old mice display greater variability in telomere length among
β-cells compared to 12-day old mice, suggesting replication is not uniform across the population.
In adult mice, β-cell replication is the principle mechanism for maintenance of β-cell mass,
driven by a small number of mitotically competent cells, which declines with age47,177–179. The
number of replicating β-cells increases under metabolic stress and inflammation, but this effect is
also restricted by age48,51,175,180–182. Several other markers have been associated with β-cell aging
and functional decline, including expression of IGF1R and P53BP1, and increased lipid
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storage183,184. The degree of heterogeneity displayed by these markers is unknown. While β-cell
replication plays a central role in generating and maintaining β-cell mass, the notion that it is the
sole mechanism for β-cell replacement has been challenged.
Insulin positive cells are observed in ductal tissue following partial pancreatectomy and
overexpression of gastrin and TGFα in ductal cells185–188. Prolonged glucose infusion induces
ductal clusters to become PDX1 positive, with some expressing insulin189. These extra-insular βcells are also proliferative, as they are observed in aggregates <50 µm190–192. Like low-perfused
islets, ductal cells may provide a reserve pool of insulin production during glycemic stress.
Several groups have identified a pancreatic multipotent progenitor (PMP) population25,76,193,194.
These cells express insulin but lack Glut2 expression, likely preventing them from performing
glucose-stimulated insulin secretion. Interestingly, these cells have the capacity to proliferate and
generate multiple endocrine cell types, including functional β-cells. Further, replication of these
cells is induced by hyperglycemic conditions, suggesting they too may play a role in glycemic
stress response. The existence of PMPs has been heavily challenged, as other studies fail to
identify such populations, even following substantial β-cell loss177,195,196. Much of the argument
centers on the weaknesses of lineage tracing, reviewed in197, and the low likelihood that these
cells contribute meaningfully to functional β-cell mass. What relationship, if any, exists between
ductal-derived β-cells and PMP’s remains to be characterized.
α-cells have been shown to acquire β-cell-like properties in response to extreme β-cell
loss and genetic perturbations198–202. However, the utility of these observations is questioned
because of lack of evidence that this phenomenon occurs in normal islet homeostasis. A study by
van der Meulen et al. addressed some of these criticisms by identifying a Glut2-low population
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of β-cells residing within the islet periphery72. Using lineage tracing, they showed that these
“virgin” β-cells do not express Glut2 because they are an intermediate in α-to-β-cell
transdifferentiation. These cells do not import meaningful amounts of glucose following 50
minutes of exposure and are resistant to STZ-induced β-cell death, likely due to lack of Glut2
expression.

These

cells

transition

into

Glut2-high

β-cells

overtime,

making

them

indistinguishable from conventional β-cells. A recent study challenged that Glut2-low cells
represent an α-β transitional cell, and that massive β-cell loss induces transdifferentiation203.
Feng et al. used an STZ model of diabetes to assess the fates of Glut2-high and Glut2-low β-cells
using single cell RNAseq. While Glut2-low β-cells survive STZ treatment, they do not mature
into Glut2-high cells in 9 months post-treatment, contradicting van der Meulen et al.’s findings72.
Further, they did not find evidence for α-β-cell transdifferentiation at the transcriptional level.
However, these mice were given insulin pellets to ensure long-term survival, which may
confound interpretation. Regardless of their relevance to normal insulin homeostasis, the
transdifferentiation of ductal or α-cells into β-cells remains an appealing therapeutic approach for
diabetes. Neither ductal or α-cell populations are reduced by diabetes, providing a steady source
of potential β-cells. Further, α-cells display a high degree of resistance to viral and metabolic
induced stress, suggesting that β-cells derived from α-cells could retain these properties204,205.
The potential sources for β-cells are summarized in Figure 1.1A. At this junction, it is not clear
how β-cells from different developmental sources display meaningful heterogeneity. Given the
influence of the β-cell microenvironment on function, there is no reason to believe β-cells from
dorsal or ventral islets, β-cell replication, differentiation of PMPs, or transdifferentiation of βcells would behave identically. Understanding how β-cells functionally mature will provide
insight into how β-cell location, age, and function interconnect.
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1.7 Maturation influences β-cell heterogeneity
How β-cells acquire specialized functionality has been characterized in depth. In mice,
initial β-cell maturation proceeds in two developmental phases206–209. The first phase lasts two
weeks following birth, a period of rapid β-cell proliferation and simultaneous waves β-cell
apoptosis, which coordinate to set the foundation for β-cell mass210,211. Surviving cells begin to
express transcription factors required for β-cell function and are considered immature172,206,212.
The second developmental phase starts at weaning, characterized by changes in metabolic
pathways and functional maturation209,213. Comparing β-cells from 4-week old mice and 16-week
old mice reveals differential expression of thousands of genes, while only 193 genes were
differentially expressed between 3- and 26-month old mice, suggesting β-cells change
substantially early in life and little in adulthood96,214. Pseudotime analysis of individual β-cells
reveals differential expression of genes associated with amino acid uptake, ROS production, and
cellular respiration during functional maturation101,178. Markers of mature β-cells include Glut2,
Ins2, Mafa, Nkx6.1, NeuroD, and Ucn3 while immature β-cells express Hk1, PaxA, Pax6, and
Mafb3,215–218. In humans, MAFB is expressed in mature β-cells and knockout of MAFB results in
β-cell dysfunction, suggesting it plays a nonredundant role from MAFA219–221. A set of
“disallowed” genes including Hk1, Ldha, Mct1, Rest, and Pdgfrα, have been identified as being
prohibited from expression in mature β-cells213,222,223. Many of these genes are involved in
glucose metabolism and exocytosis and would interfere with glucose-stimulated insulin
release224. The molecular machinery driving insulin release is similar in both mature and
immature β-cells, with a few key differences218. Neonatal islets have elevated basal insulin
secretion due high glucose sensitivity218,225. Interestingly, when immature and mature β-cells are
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depolarized independent of glucose sensing, both release similar levels of insulin, suggesting
their differences lie in glucose sensing and metabolism218. Immature β-cells express Hk1, which
has a higher affinity for glucose than Gck, which is expressed in mature β-cells226–228. Thus, it
takes higher concentrations of glucose to trigger glycolysis and downstream oxidative
phosphorylation in mature β-cells, which may explain differences in insulin secretion between
these two classes of cells. Other components of the insulin secretion pathway, including genes
involved in glycolysis, the TCA cycle, oxidative phosphorylation, and exocytosis are also
differentially expressed between mature and immature β-cells209,213,229. An overview of immature
β-cell characteristics is shown in Figure 1.2A.
Maturation state appears to be a heterogeneous trait in adult β-cells and is associated with
replicative capacity214,230,231. Szabat et al. used a Pdx1/Insulin dual reporter to discover that 25%
of β-cells in humans and mice are Pdx1 positive but have low insulin expression74. These cells
have an immature gene expression profile, including elevated Mafb expression, and low Gck and
Glut2 expression. Immature cells have high proliferative capacity and poor insulin secretion, and
functionally mature without proliferation in vitro. Bader et al. reinforced these findings by
identifying a subpopulation of immature β-cells based on lack of Fltp expression (discussed
below)45 These cells have high replicative capacity at the expense of mature β-cell function. The
replication/maturation dichotomy was illustrated by Klochendler et al., who used a fluorescent
reporter mouse for cyclin B1, which is active only during mitosis230. This allowed sorting of cells
based on a mitotic state. Performing RNAseq on these populations revealed a global increase in
cell cycle genes, but a distinct downregulation of genes associated with β-cell function including
Glut2 and Ucn3 as well as enrichment for genes regulated by mature β-cell transcription factors.
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In human β-cells, a clustering approach to simultaneously assess intracellular Ca2+ dynamics in
~300 islet cells revealed two distinct populations based on Ca2+ flux frequency and amplitude,
suggesting mature and immature states232. The dichotomy between replication and maturation is
associated with ER stress response178,233. These observations have implications for understanding
post-natal β-cell expansion; individual β-cells cannot simultaneously replicate and be functional.
Observations that β-cell replication and maturation are at odds were coalesced into a
unified theory by Bader et al., who separated β-cells into mature and immature populations based
on expression of Flattop (FLTP)45. FLTP is expressed in tissues where the Wnt/Planar cell
polarity pathway is active and is necessary for epithelial organization and architecture234. Bader
et al. used an islet specific FLTP reporter and found expression increases throughout β-cell
maturation, resulting in 80% of cells positive for FLTP in adult mice. Transcriptional analysis
revealed 997 genes differentially expressed between populations, with positive cells expressing
markers of maturation including Ucn3, Mafa, mitochondrial oxidative phosphorylation genes,
and insulin secretion genes, while negative cells expressed genes associated with MAP kinases,
Gcprs, and had low Glut2 expression. FLTP(-) cells are more proliferative, with 8% of negative
cells staining Ki67(+) at postnatal day 11, compared to 2% of FLTP(+) cells. In high fat dietinduced islet hypertrophy, the FLTP(+) population expanded in line with heightened metabolic
demand, suggesting that the progeny of FLTP(-) cells can become FLTP(+). Morphologically,
FLTP(+) cells are polarized and found in rosette structures. Re-aggregated FLTP(-) cells in vitro
have lower glucose stimulated insulin secretion than positive cells, suggesting they are
functionally immature. Knockout of FLTP resulted in very mild functional changes, suggesting
FLTP is a passive marker for maturation. In humans, islet FLTP expression correlates with
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glucose tolerance, with healthy donors expressing higher levels of FLTP than prediabetic and
diabetic donors. Thus, FLTP distinguishes proliferative and metabolically active β-cells and
suggests β-cell maturation could be driven by the polarization process. The specific mechanism
through which the wnt/PCP pathway effects β-cell function is unknown, but it may involve
cytoskeleton components and gene expression changes. These findings raise questions about βcell heterogeneity. Are FLTP(-) cells part of the 25% of β-cells that do not increase metabolic
activity in high glucose56? Could these be the Glut2-low cells reported in PSA-NCAM low cells
or E-cadherin low cells73,81–83? Or the poor functioning β3 and β4 cells identified by Dorrell et
al.110? It is possible that many of these studies are converging on overlapping populations of
cells. The differences between immature and mature β-cells are highlighted in Figure 1.1B and
Figure 1.2B.
Dedifferentiation of mature β-cell identity is a central component of β-cell dysfunction in
type 2 diabetes215,235–239. This is attributed to many factors, including oxidative stress, glucose
and lipid toxicity, and inflammation235,240–242. Dedifferentiated β-cells have decreased insulin
expression and decreased insulin secretion, thus contributing to loss of glycemic control3,93,240.
Dedifferentiation is characterized by decreased expression of β-cell-specific transcription factors
Pdx1, Nkx6.1, and MafA, increased expression of developmental genes, Ngn3, Oct4, Nanog, and
L-myc, and expression of disallowed genes, Ldha, Mct1, G6pc, and Hk126,222,242–244. These
changes are linked to decreased expression of Foxo1, which mediates Pdx1 activity3,26,245–247. An
overview of the characteristics of dedifferentiated β-cells is shown in Figure 1.2C. Moving
hyperglycemia-induced dedifferentiated β-cells into a healthy environment can reverse the
dedifferentiation phenotype215,236,248. Insulin administration can also return immature cells to a
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functional state, suggesting therapeutic intervention is possible238. We recently published
findings on obese SM/J mice, which spontaneously transition from hyperglycemic-obese to
normoglycemic-obese with age249. Underlying this transition is improved β-cell function,
including increased insulin content and glucose-stimulated insulin secretion. This suggests SM/J
β-cells are likely undergoing maturation and show that β-cell functionality can be improved in
vivo in the context of obesity. Evidence for dedifferentiated β-cells in diabetic humans based on
single cell RNA sequencing data has been established98. The parallels between nascent β-cell
maturation and diabetes-induced dedifferentiation have not been fully explored. Greater
understanding of the β-cell maturation process may provide insight into how dedifferentiated βcells may be rescued, opening exciting new avenues for therapeutic interventions.
1.8 Stress response influences β-cell heterogeneity
An emerging paradigm suggests that β-cells undergo cycles of insulin production and
stress response, due to the unique physiological demands they face. Insulin synthesis accounts
for 10% of total protein during basal conditions, compared to 50% in stimulated conditions59,250.
Insulin is highly prone to misfolding251–253. Once misfolded, insulin can be refolded or degraded.
Under demanding conditions, misfolded proteins accumulate, and the UPR machinery is
activated to clear the misfolded proteins254. The high rate of oxidative phosphorylation in β-cells
also generates ROS, which can damage nascent proteins255. β-cells have been characterized as
having low antioxidant defense, and thus are more susceptible to stress256,257. This combination
of factors make the insulin secretion responsibilities of β-cells a unique cellular challenge.
Many single cell studies identified subpopulations of β-cells based on an ER stress
response signature, at the expense of genes related to mature β-cell function21,90,92,258. Xin et al.
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performed pseudotime analysis on human β-cells and identified the transcriptional trajectory
between the three β-cell states: High Insulin/Low UPR, Low Insulin/High UPR, and Low
Insulin/Low UPR21. This suggests mature β-cells undergo a cycle: Elevated insulin production,
followed by a period of low insulin production and UPR activation to clear misfolded insulin
protein, then a rest period of low insulin and low UPR activity. Under this hypothesis, only a
fraction of β-cells produce insulin at a given time while others are resting/recuperating259. This is
supported by evidence from isolated human and mouse β-cells, where a small fraction of cells
are responsible for the majority of insulin secretion57,60,61. Xin et al. also found Low Insulin/High
UPR cells were more proliferative, suggesting they are given the chance to replicate during
recovery21. Cells under glycemic stress would produce more insulin, thus would have a great
degree of UPR activation. Whether replication is induced by the intensity or length of UPR
response is unknown. This theory is supported by Szabat et al., who used a Pdx1/INS dual
reporter to show that β-cells transition between periods of high and low insulin in ~27 hour
cycles259. Activation of UPR in human β-cells also stimulates proliferation233. A summary of βcell stress response cycling is summarized in Figure 1.1D. Could the interplay between these
metabolic states explain the morphological, functional, and transcriptional heterogeneity seen in
β-cells, particularly the identification of β-cell subpopulations in single cell RNAseq data? Loss
of β-cell mass by apoptosis occurs in diabetes, driven in part by failure of the ER stress response.
In response to prolonged stress, what drives β-cells to undergo apoptosis, dedifferentiation, or
replication? Identifying cells that are prone to a specific fate may help prevent loss of β-cell
mass.
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1.9 Conclusion
Our understanding of β-cell heterogeneity has increased over decades, revealing several
trends. First, there is a morphological and functional dichotomy between peripheral and core βcells31,36,125. This is attributed to topology including homotypic contacts, heterotypic contacts,
vascularization, and proximity to axon terminals60,124,127,129,153,164. Further, islet topology changes
in diabetes, highlighting the importance of understanding the role of the β-cell
microenvironment120,122,123. The developmental origins of the β-cell, including neogenesis, β-cell
replication, and differentiation from another cell may play a role in heterogeneity. These
different sources produce adult β-cells that vary in cellular age, which is associated with
functional decline176,183,184. How the distribution of young and old β-cells influences islet
function and stress response is unknown, but it clearly influences replicative capacity177–179. The
existence and relevance of ductal cell-, α-cell-, and PMP derived-β-cells remains controversial,
but they are appealing avenues for diabetic therapy because of their stress resistance
characteristics72,76,185,203–205. β-cell function and replication are at odds during the initial
maturation process, resulting in decreased mitotic index and improved glucose-stimulated insulin
secretion172,209,213,215,216. In adults, a subpopulation of cells retain immature gene expression and
functional characteristics, including higher replication rates45,74,230,232,260. Loss of mature β-cell
identity is a hallmark of diabetes and disrupts the insulin-glucose axis215,235–237. Can studying the
differences between immature and mature β-cell populations in healthy adults inform diabetic
therapy? Variation in β-cell metabolic activity is associated with differences in stress
susceptibility, suggesting mature and immature populations likely succumb to different fates in
diabetes51,56,154–156. The relationship between β-cell maturation, replication, and stress response is
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complicated by observations that mature β-cells undergo a stress response cycle, and that UPR
activation can stimulate replication21,178,233,259. The relationships among classes of variation,
sources of variation, and proposed subtypes is summarized in Figure 1.1. These likely contribute
to the variance seen in single cell RNA sequencing studies, many of which cluster cells based on
expression of stress response genes21,90,92,258.
Assessment of variation in gene expression, protein levels, morphology, and function has
led several groups to identify β-cell subpopulations. Given the frequency of these populations,
there is likely substantial overlap. This includes FLTP (-), ST8SIA1 (+), PSA-NCAM-low, ECadherin-low, and Glut2-low “virgin” β-cells all possibly identifying adult immature β-cells
based on gene expression and functional characteristics45,72,81,83,260. How much of the
transcriptional heterogeneity identified in single cell RNA sequencing is driven by the ER stress
response cycling21,90,258,259? Further, does ER stress response cycling influence the immature βcell population? This could explain the elevated, but not dramatic increase in β-cell replication
seen in immature cells. These observations raise questions over requirements for subtype
classification. Are subtype traits under unique selective pressure, different from the general
population? What are the temporal requirements for a subtype? What about cell plasticity, the
ability of subtypes to interconvert? Should a subtype require a unique functional and
transcriptional profile? Answering these questions will clarify which heterogeneous traits are
critical for building subtype identities.
Techniques including FACS and single cell RNA sequencing are mainstays in shaping
understanding of β-cell heterogeneity. However, these techniques have limitations, as they fail to
capture functional, transcriptional, and topological information simultaneously. Further,
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questions about the temporal regulation of β-cell heterogeneity are becoming unavoidable.
Lineage tracing is the gold standard for understanding developmental trajectories but has
received considerable criticism for its shortcomings including promoter leakage, low labeling
efficiency, and inability to recapitulate native expression patterns197. Dual trace techniques may
overcome some of these issues261. Several new techniques promise to improve our understanding
of β-cell heterogeneity, including preserving live sections using perfluorocarbon262,263. This will
allow temporal and topological assessment of β-cells and provide the opportunity to test the
effects of various compounds on β-cell growth and function in vivo. This will also provide a new
platform for lineage tracing. SeqFISH allows one to probe the expression of hundreds of genes
simultaneously in intact tissue, which can couple extensive transcriptional information with
topology264. Patch-Seq couples β-cell ion-channel activity with single cell RNA sequencing,
linking functionality with gene expression63. This is an exciting time to be in the field of β-cell
heterogeneity, as many of the discoveries made over decades of research are slowly coalescing
into a unified understanding of how and why β-cells differ. Whether these discoveries will make
meaningful improvements in the way diabetes is studied and treated remains to be seen.
1.10 Scope of Thesis
Previous work established that obese SM/J mice transition from hyperglycemic at 20
weeks of age to normoglycemic by 30 weeks of age. Given the importance of β-cell function in
maintaining glycemic control, we sought to explore how obese SM/J β-cells change during this
remarkable period. By contrast β-cells in hyperglycemic-obese and normoglycemic-obese mice,
we aim to identify the genes and pathways associated with improved glucose homeostasis, which
may reveal novel strategies that improve β-cell function in obesity. Given the increasing
25

relevance of β-cell heterogeneity in diabetes research, we also sought to characterize β-cell
subpopulations in obese SM/J mice, and how they contribute to the hyper- and normoglycemicobese states. By integrating phenotypic information with subpopulation structure, a more
complete picture of β-cell function in obese SM/J mice can be achieved. The following chapters
explore how obese SM/J β-cell’s change from a morphological, functional, transcriptional, and
single cell perspective.
In chapter 2 we characterize insulin homeostasis, islet morphology, and β-cell function
during SM/J’s diabetic remission. Obese SM/J mice dramatically increase circulating and
pancreatic insulin levels, improve insulin sensitivity, and increase β-cell mass. Functional
assessment reveals obese SM/J mice increase glucose stimulated insulin secretion, decrease basal
insulin secretion, and increase islet insulin content. In chapter 3, we integrate islet single-cell
and bulk RNA sequencing data. We identify 4 β-cell subpopulations associated with insulin
secretion, hypoxia response, cell polarity, and stress response are influenced by age, sex, and
diet. Network analysis identifies fatty acid metabolism gene expression modules associated with
the hyperglycemic-obese state. We identify Pdyn and Fam151a as candidate regulators of β-cell
function in obesity. This study establishes that β-cell mass expansion and improved β-cell
function underlie the resolution of hyperglycemia and uses a novel data integration method to
explore how β-cells respond to obesity and glycemic stress, helping to define the relationship
between β-cell heterogeneity and diabetes.
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1.11 Figures and Legends

Figure 1.1. Classes, sources, and subtypes of β-cell heterogeneity. β-cells display variation in
gene expression (red), protein level (blue), morphology (green), and function (purple).
Heterogeneity is influenced by β-cell source (A), maturation state (B), topology (C), and stress
response (D). (A) β-cell sources include neogenesis during development, transdifferentiation of
α- and ductal cells, β-cell replication, and differentiation PMPs. (B) Immature β-cells (B1) and
mature β-cells (B2) present distinct gene expression, protein, and functional characteristics. (C)
Topology influences β-cells through the core-mantel structure, where peripheral β-cells (C1)
have more heterotypic contacts, resulting in low glucose sensitivity and insulin release compared
to core β-cells (C2). (D) β-cell stress response causes β-cells to cycle between states of high
insulin with low UPR, low insulin with high UPR, and a period of low insulin with low UPR.
Two subtypes of adult β-cells have been identified: Hub cells (E1) are characterized by very high
Gck expression but low insulin expression, and high number of homotypic contacts. Extreme βcells (E2) are located near the islet core, characterized by very high insulin expression but low
mature insulin protein stores. It is unclear if hub cells and extreme β-cells stem from a mature or
immature population. PMP – Pancreatic multipotent progenitor, INS – Insulin expression, Insulin
– Insulin protein, UPR – Unfolded protein response.
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Figure 1.2. Maturation state heterogeneity in pancreatic beta β-cells. (A) Following birth,
neonatal β-cells are transcriptionally and functionally immature, characterized by Pax6, Hk1,
Paxa, and Mafb expression, very high proliferation rates, very high basal insulin secretion, and
high glucose sensitivity. Maturation is facilitated by transition to a carbohydrate rich diet at
weaning. (B) Mature β-cells are characterized by expression of Mafa, Ucn3, and Fltp, high
expression of insulin, Glut2, and Gck. These β-cells have low proliferation rates but high
glucose-stimulated insulin secretion. A subset of adult β-cells maintain an immature-like profile,
including Mafb expression, low expression of insulin, Glut2, and Gck, and lack Fltp expression.
These cells have elevated proliferation rates but low glucose-simulated insulin secretion.
Whether these cells differ in developmental origin or can interconvert is unknown. (C) In
diabetes, glucotoxicity, lipotoxicity, and inflammation induces variable fates in β-cells, including
dedifferentiation, apoptosis, and replication. Dedifferentiated β-cells have expression of
developmental genes including Ngn3, Oc4, and Nanog, low expression of genes associated with
mature beta cells including Pdx1, Mafa, Foxo1, and insulin, and low glucose-stimulated insulin
secretion. Other fates for β-cells in diabetes include replication and apoptosis. The relationship
among adult mature and immature cells and the three fates in diabetes remain to be described.
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β-cell mass in obese SM/J mice
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2.1 Abstract
Maintenance of functional β-cell mass is critical to preventing diabetes, but the physiological
mechanisms that cause β-cell populations to thrive or fail in the context of obesity are unknown.
High fat-fed SM/J mice spontaneously transition from hyperglycemic-obese to normoglycemicobese with age, providing a unique opportunity to study β-cell adaptation. Here, we characterize
insulin homeostasis, islet morphology, and β-cell function during SM/J’s diabetic remission. As
they resolve hyperglycemia, obese SM/J mice dramatically increase circulating and pancreatic
insulin levels while improving insulin sensitivity. Immunostaining of pancreatic sections reveals
that obese SM/J mice selectively increase β-cell mass but not α-cell mass. Obese SM/J mice do
not show elevated β-cell mitotic index, but rather elevated α-cell mitotic index. Functional
assessment of isolated islets reveals that obese SM/J mice increase glucose stimulated insulin
secretion, decrease basal insulin secretion, and increase islet insulin content. These results
establish that β-cell mass expansion and improved β-cell function underlie the resolution of
hyperglycemia, indicating that obese SM/J mice are a valuable tool for exploring how functional
β-cell mass can be recovered in the context of obesity.
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2.2 Introduction
Obesity and diabetes are a deadly combination, compounding risk for cardiovascular disease,
cancer, and stroke265–267. Obesity raises the risk of developing type 2 diabetes 27-76 fold, while
approximately 60% of individuals with diabetes are obese268–271. Chronic obesity exerts glycemic
stress on pancreatic β-cells, causing dysregulation and dysfunction, ultimately resulting in
hyperglycemia272–275. Despite the stress obesity places on β-cells, 10-30% of obese individuals
maintain glycemic control and are at low risk for developing diabetes276. These low-risk obese
individuals have elevated β-cell mass and improved insulin secretion compared to BMI-matched
diabetic-obese individuals2,13,277,278. Understanding the differences in β-cell physiology between
these populations may reveal therapeutic strategies for maintaining and improving glycemic
control in obese individuals.
Recent work suggests β-cells do not respond uniformly to glycemic stress, rather they
experience variable fates including dedifferentiation, replication, and apoptosis2,27,279.
Understanding how these changes mediate diabetic risk is complicated by β-cell heterogeneity.
β-cell populations include subtypes that specialize in basal insulin secretion, β-cell replication,
coordinating “hub” cells, and β-cells derived from transdifferentiated α-cells, each of which
differ in glycemic stress response23,25,280. Thus, determining what differentiates nondiabeticobese and diabetic-obese populations requires connecting β-cell subtypes to their fate in
prolonged glycemic stress.
Like in humans, diabetic risk in obese mice depends on genetic background281–284. Variation
in β-cell heterogeneity likely underlies variability in islet stress response, and thus needs to be
accounted for when comparing nondiabetic-obese and diabetic-obese populations. Loss of
function mutations in leptin (ob/ob) and leptin receptor (db/db) provide insight into β-cell
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physiology in nondiabetic-obese and diabetic-obese states within individual mouse strains2,285–
288

, however leptin and its receptor play a critical role in β-cell function independent of obesity,

limiting interpretations of these studies289. No current mouse model is well-suited to examine
physiological differences in β-cell health between nondiabetic-obese and diabetic-obese states.
The SM/J inbred mouse strain has traditionally been used to study interactions between diet
and metabolism, and more recently has uncovered genetic architecture underlying diet-induced
obesity and glucose homeostasis290–295. After 20 weeks on a high fat diet, SM/J mice display
characteristics of diabetic-obese mice, including elevated adiposity, hyperglycemia, and glucose
intolerance296. We have previously shown that by 30 weeks of age, high fat-fed SM/J mice enter
diabetic remission, characterized by normalized fasting blood glucose, and greatly improved
glucose tolerance and insulin sensitivity297. Importantly, these changes occur in the context of
sustained obesity. Given the central role of β-cell health in susceptibility to diabetic-obesity, we
hypothesize that obese SM/J mice undergo restoration of functional β-cell mass during the
resolution of hyperglycemia. This study focuses on how insulin homeostasis, β-cell morphology,
and β-cell function change during this remarkable transition and establishes SM/J mice as a
useful model for teasing apart diabetic-obese and nondiabetic-obese states.

2.3 Methods
Animal husbandry and tissue collection. SM/J mice were obtained from The Jackson Laboratory
(Bar Harbor, ME). Experimental animals were generated at the Washington University School of
Medicine and all experiments were approved by the Institutional Animal Care and Use
Committee in accordance with the National Institutes of Health guidelines for the care and use of
laboratory animals. Mice were weaned onto a high fat diet (42% kcal from fat; Envigo Teklad
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TD88137) or an isocaloric low fat diet (15% kcal from fat; Research Diets D12284), as
previously described297. At 20 or 30 weeks of age, mice were fasted for 4 hours, and blood
glucose was measured via glucometer (GLUCOCARD). Mice were then injected with an
overdose of sodium pentobarbital, followed by a toe pinch to ensure unconsciousness. Blood was
collected via cardiac puncture and pancreas was detached from the spleen and duodenum.
Serum and pancreatic insulin measurements. Blood obtained via cardiac puncture was spun at
6000 rpm at 4°C for 20 minutes to separate plasma, which was collected and stored at -80 °C.
Whole pancreas was homogenized in acid ethanol and incubated at 4°C for 48 hours, shaking.
Homogenate was centrifuged at 2500 rpm for 30 min at 4°C. Supernatant was collected and
stored at -20°C. Protein content was measured using Pierce BCA Protein Assay kit (Thermo
Scientific) according to manufacturer’s instructions and read at 562 nm on the Synergy H1
Microplate Reader (Biotek). Insulin ELISA (ALPCO 80-INSMR-CH01) was used to measure
plasma and pancreatic insulin levels following manufacturer’s instructions.
Insulin Tolerance Test. At 19 or 29 weeks of age, mice were fasted for 4 hours prior to
procedure. Insulin (humulin) was prepared by mixing 10 ul insulin with 10 ml sterile saline.
Mice were injected with 3.75 ul insulin mixture/g bodyweight. Blood glucose levels were
assessed from a tail nick at times = 0, 15, 30, 60, and 120 minutes via glucometer
(GLUCOCARD).
Islet Histology and Analyses. At the time of tissue collection, whole pancreas was placed in 3 mL
of neutral buffered formalin. These samples were incubated at 4°C while gently shaking for 24
hours. Immediately afterwards, samples were placed into plastic cages and acclimated to 50%
EtOH for 1 hour. Samples were then processed into paraffin blocks using a Leica tissue
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processor with the following protocol: 70% EtOH for 1 hour x 2, 85% EtOH for 1 hour, 95%
EtOH for 1 hour x 2, 100% EtOH for 1 hour x 2, Xylenes for 1 hour x 2, paraffin wax. Pancreas
blocks were sectioned into 4 μm thick sections. Four samples per individual were randomly
selected, at least 100 μm apart.
Slides were incubated at 60°C for 1 hour, then placed in xylenes to remove remaining paraffin
wax. Slides were then rehydrated using successive decreasing EtOH concentrations (xylenes x 2,
50% EtOH in xylenes, 100% EtOH x 2, 95% EtOH, 70% EtOH, 50% EtOH, H2O). Slides were
incubated in sodium citrate (pH 6) at 85°C for 30 minutes, then submerged in running water for
5 minutes. Slides were washed with 0.025% Triton X-100 in TBS and blocked in 10% normal
donkey serum for 1 hour (Abcam ab7475), followed by incubation with primary antibody
overnight at 4°C. [Primary antibodies: rat anti-insulin (1:100, R&D MAB1417), mouse antiglucagon (1:100, Abcam ab10988), and rabbit anti-phospho-histone H3 (1:100, Sigma
SAB4504429)]. After an additional wash, secondary antibody was applied for 1 hour at room
temperature. [Secondary antibodies: donkey anti-rabbit 488 (1:1000, Abcam ab150061), donkey
anti-mouse 647 (1:1000, Abcam ab150107), and donkey anti-rat 555 (1:1000, Abcam ab
150154)]. Fluoroshield Mounting Medium with DAPI (Abcam) was applied to seal the coverslip
and slides were stored at 4°C. Imaging was performed using the Zeiss AxioScan .Z1 at 20X
magnification and 94.79% laser intensity.
Background was subtracted from DAPI, insulin, glucagon, and phospho-histone H3 images using
ImageJ. DAPI channel was used to identify total nuclei in CellProfiler. Insulin and glucagon
channels were combined and overlaid on the DAPI image to identify islet nuclei. Insulin (INS+)
staining overlaid with DAPI identified β-cell cells, glucagon (GCG+) staining overlaid with
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DAPI identified α-cells, based on the proximity of the signal to a given nuclei. Phosphohistone
H3 (PHH3+) staining identified mitotic nuclei. Total nuclei, islet cells, β-cells, α-cells, and
mitotic nuclei were summed across 4 slides for each individual. Islet, β-cell, and α-cell mass is
reported as fraction of total nuclei. Mitotic islet index is reported as proportion of β-cells and αcells positive for phosphohistone H3. Mean β-cell area was calculated by dividing the total INS+
area by the number of INS+ cells. Mean β-cell area is reported for each individual. Islets with
diameter < 50 µm were discarded.
Islet isolation. Pancreas was removed and placed in 8mL HBSS buffer on ice. Pancreas was then
thoroughly minced. Collagenase P (Roche) was added to a final concentration of 0.75 mg/ml.
Mixture was then shaken in a 37°C water bath for 10-14 minutes. Mixture was spun at 1500 rpm
for 2 minutes. The pellet was washed twice with HBSS. The pellet was re-suspended in HBSS
and transferred a petri dish. Hand-selected islets were placed in sterile-filtered RPMI with Lglutamine (Gibco) containing 11mM glucose, supplemented with 5% pen/strep and 10% Fetal
Bovine Serum (Gibco). Islets were rested overnight in a cell culture incubator set to 37°C with
5% CO2.
Glucose Stimulated Insulin Secretion and Islet Insulin Content. Islets of roughly equal size were
equilibrated in KRBH buffer containing 2.8 mM glucose for 30 minutes at 37°C. 5 islets were
hand selected and placed in 150 µl KRBH containing either 2.8 or 11 mM glucose. Tubes were
placed in a 37°C water bath for 45 min. Islets were then spun at 2000 x g, hand-picked with a
pipette, and transferred from the secretion tube and placed in the content tube with acid ethanol.
The content and secretion tubes were stored at -20°C overnight. Each condition was performed
in duplicate for each individual. Mouse insulin ELISA (ALPCO 80-INSMU-E01) was performed
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according to manufacturer’s instructions, with the secretion tubes diluted 1:5, and content tubes
diluted 1:100. Normalized insulin secretion was calculated by dividing the secreted value by the
content value. Glucose stimulated insulin secretion was calculated by dividing the normalized
insulin secretion at 11mM glucose by the normalized insulin secretion at 2.8 mM glucose. Each
sample was measured in duplicate. Total islet protein within each content tube was measured
using Pierce BCA Protein Assay kit (Thermo Scientific) according to manufacturer’s instructions
and read at 562 nm on the Synergy H1 Microplate Reader (Biotek). Islet insulin content was
calculated by dividing the insulin level in the content tubes by the total protein value.
Statistical analyses. Phenotypes were assessed for normality by a Shapiro-Wilk test, and outliers
removed. ANOVA revealed that sex-by-diet-by-age interactions did not contribute meaningful
variance to any phenotype so males and females were pooled at each time point. A student’s ttest was used to assess significance between two cohorts, while a one-way ANOVA with
Tukey’s Post Hoc test was used to assess significance among multiple cohorts. Pearson’s
correlation was used to determine strength of correlation among variables. P-values < 0.05 were
considered significant.

2.4 Results
Obese SM/J mice increase insulin levels and improve insulin sensitivity. The resiliency of β-cells
distinguishes nondiabetic-obese and diabetic-obese individuals287,288,298–303. While both groups
develop hyperinsulinemia, diabetic-obese individuals become insulin resistant, leading to β-cell
dysfunction, hypoinsulinemia, and hyperglycemia. Our previous work shows that obese SM/J
mice spontaneously transition from hyperglycemic to normoglycemic with age297. Principle to
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this is a 40 mg/dl decrease in fasting glucose levels in high fat-fed SM/J mice between 20 and
30-weeks (Figure 2.1A). We first sought to characterize how insulin homeostasis changes during
this transition. Interestingly, 20-week high fat-fed SM/J mice have comparable levels of plasma
and pancreatic insulin levels compared to age-matched low fat-fed mice (Figure 2.1B-C). By 30
weeks, high fat-fed SM/J mice increase circulating insulin levels 5.3-fold and pancreatic insulin
levels 1.9-fold, in line with other models of hyperinsulinimic nondiabetic-obesity304–306. We
sought to test for peripheral insulin resistance via an insulin tolerance test (ITT), as insulin
resistance is a known mechanism for increasing circulating and pancreatic insulin levels.
Surprisingly, 20-week high fat-fed SM/J mice display insulin resistance compared to low fat-fed
mice, however, insulin sensitivity is restored by 30 weeks (Figure 2.1D-E). The simultaneous
increase in insulin production and improved insulin sensitivity is unprecedented and suggests a
novel mechanism beyond insulin resistance for enhancing β-cell insulin secretion.

Obese SM/J mice increase islet mass during resolution of hyperglycemia. In humans and mice,
obesity initially increases islet mass, and maintenance of that mass in part differentiates
nondiabetic-obese individuals from diabetic-obese individuals2,13,47,277,307,308. To understand the
source of increased insulin production in obese SM/J mice, we examined islet morphology
during the resolution of hyperglycemia. To quantify islet mass and number, β-cell mass, α-cell
mass, and mitotic index, we randomly selected 4 sections per fixed pancreas and stained with
antibodies against insulin, glucagon, and phospho-histone H3. Representative images of
immuno-stained pancreatic sections for 30-week high fat-fed mice and 30-week low fat-fed mice
are shown in Figure 2.2A-B. Consistent with other mouse models of obesity, 20-week high fatfed SM/J mice have a 2.75-fold increase in total islet mass compared to low fat-fed mice (Figure
37

2.2C). This increased mass is driven by an increase in both median islet area and number of
islets (Figure 2.2D-E). Islet mass is further elevated 2-fold between 20- and 30-weeks in high
fat-fed mice, while the islet population remains unchanged in low fat-fed mice. A full summary
of the islet quantification is presented in Table 2.1. Distribution of islet size is shown in Figure
2.5, along with corresponding density plot for each cohort. Islet mass correlates with BMI in
obese humans309, a similar correlation is seen between islet mass and body weight in high fat-fed
SM/J mice (Fig. 2F).

Obese SM/J mice increase β-cell mass and α-cell replication. To identify the source of the
increased islet mass in high fat-fed SM/J mice, we quantified the relative representation of βcells and α-cells within each cohort. Increased islet mass in 20-week high fat-fed mice is driven
by a 3.3-fold increase in the number of β-cells and a 2.5-fold increase in the number of α-cells
compared to low fat mice, while growth between 20- and 30-week high fat-fed mice is driven by
a further 2.2-fold increase in β-cell number (Figure 2.3A-B). In obesity, islet mass expands
primarily through β-cell hyperplasia15,27,47,310. Mean β-cell area is not different across age and
dietary cohorts (Figure 2.6) We quantified mitotic index of β- and α-cells in our model using
phosphohistone H3 and assessed how mitotic index relates to β-cell mass during the resolution of
hyperglycemia in obese SM/J mice. Surprisingly, calculation of β-cell mitotic index reveals
similar rates of β-cell replication across cohorts (Figure 2.3C), while α-cell mitotic index is
elevated 6-fold in high fat-fed mice compared to low fat-fed controls (Figure 2.3D). Examining
the relationship between β-cell mitotic index and β-cell mass in high fat-fed mice reveals β-cell
replication correlates with β-cell mass in 20-week mice, but not 30-week mice (Figure 2.3E-F).
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Obese SM/J mice increase islet insulin secretion and insulin content. In conjunction with
changing β-cell morphology, diabetic-obesity is associated with altered β-cell function, including
diminished first phase insulin secretion, increased basal insulin secretion, and decreased β-cell
insulin production(12, 17, 50, 60). We sought to examine if changes in β-cell insulin secretion
and content corresponded with the resolution of hyperglycemia and expanded β-cell mass we
observe. To test this, we isolated islets from high and low fat-fed 20- and 30-week SM/J mice.
After allowing islets to rest overnight, we performed a glucose-stimulated insulin secretion assay
by subjecting islets to low (2.8 mM) or high (11 mM) glucose conditions. We find that high fatfed SM/J mice dramatically improve glucose-stimulated insulin secretion between 20 and 30
weeks of age. This includes transitioning from blunted insulin secretion under high glucose
conditions to appropriately elevated secretion (Figure 2.4A), and improvement in the ratio of
insulin secreted in response to high vs low glucose conditions (Figure 2.4B). Normalized insulin
secreted in response to elevated glucose does not differ between cohorts (Figure 2.6A). 20-week
high fat-fed mice have elevated insulin secretion in response to low glucose (Fig. 4C), consistent
with other studies of islets in type 2 diabetic humans and mice. Correspondingly, 20-week high
fat-fed SM/J mice have decreased islet insulin content (Figure 2.4D), which increases 3-fold by
30 weeks. Consistent with current understanding of the β-cell maturation process311, there is a
positive correlation between islet insulin content and glucose-stimulated insulin secretion in high
fat-fed (Figure 2.4E) and low fat-fed (Figure 2.6B) SM/J mice. This suggests that obese SM/J
mice experience β-cell maturation between 20 and 30 weeks, characterized by increased insulin
content and improved insulin secretion in response to high glucose. This spontaneous

39

improvement in β-cell health and function in the context of obesity has not been reported in other
mouse strains, suggesting a genetic basis unique to SM/J.

2.5 Discussion
The ability to maintain appropriate insulin production and secretion, termed functional βcell mass, is a central determinant of diabetic risk. In this study, we describe insulin homeostasis,
islet morphology, and β-cell function in obese SM/J mice as they transition from hyperglycemic
to normoglycemic. We determine that increased insulin production and insulin sensitivity
accompany improved glycemic control, driven by expanded β-cell mass and improved glucosestimulated insulin secretion. Our results show obese SM/J mice undergo restoration of functional
β-cell mass, providing an opportunity to explore how compensatory insulin production can be
achieved in the context of obesity.
Susceptibility to high fat diet-induced diabetes in mice depends on genetic background.
Several strains and sub-strains develop diabetic-obesity, including hyperglycemia, glucose
intolerance, and insulin resistance, consistent with the diabetic phenotypes observed in obese
SM/J mice at 20 weeks281,312,313. Remarkably, by 30 weeks, obese SM/J mice have characteristics
of diabetic-resistant obese strains, retaining glycemic control by dramatically increasing insulin
production and improving insulin sensitivity282,284,312,313. To our knowledge, this is the first report
of transient hyperglycemia in an inbred strain, although similar phenomena have been reported in
mice with the leptin receptor (db/db) mutation. C57bl/6J (db/db) and 129/J (db/db) mice are obese and
initially develop mild hyperglycemia at 8-10 weeks of age, but this resolves by 20-30 weeks,
concurrent with increased insulin production and β-cell mass285,286. Unfortunately, leptin and its
40

receptor play an important role in β-cell growth and function independent of obesity, which
confounds understanding of how genetic background mediates diabetic risk in obesity289.
Interestingly, low fat fed mice increase circulating insulin levels between 20- and 30-weeks,
despite no change in pancreatic insulin levels, insulin sensitivity, or β-cell mass.
High fat diet-induced obesity in mice can result in increased islet mass, no change, or
decreased mass282,284,313–315. Across these studies, inability to expand islet mass is associated with
hyperglycemia. In humans, islet mass correlates with BMI in nondiabetic obese-individuals,
while

diabetic-obese

individuals

have

low

islet

mass

compared

to

nondiabetic

individuals300,309,316. High fat-fed SM/J mice are unique because they have expanded islet mass at
20 weeks, yet normal insulin levels and insulin resistance. By 30-weeks, islet mass continues to
expand, driven by increased islet area and increased islet number, corresponding with increased
insulin production and improved insulin sensitivity. Islet neogenesis may contribute to the
increased islet number, and fission of large islets has been reported during development,
suggesting islets have mechanisms to maintain an appropriate size317,318.
β-cell hyperplasia is the primary driver of islet expansion in mouse models of
obesity287,288. Some nondiabetic obese mice experience increased β-cell number, but do not show
evidence for elevated β-cell replication in immunostaining of pancreatic sections282,315. This has
been attributed to islets in the tail of the pancreas being substantially more proliferative in
response to high fat diet than the body and head regions118, thus technical artifacts in sampling
could result in inflated variances which mask biological differences. This could be the case here,
given that high fat-fed SM/J’s β-cell number is far above low fat-fed controls, that their β-cell
number expands 2-fold during the resolution of hyperglycemia, yet we find no evidence for
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increased β-cell replication. However, α-cell number also expands in obesity319–321. While α-cell
mass is elevated in high fat-fed SM/J mice compared to low fat-fed controls, we find it does not
change between 20 and 30 weeks, despite substantial elevation of α-cell mitotic index.
Retention of β-cell function separates diabetic-obesity and nondiabetic obesity322–324. 20week high fat-fed SM/J mice have an insulin secretion profile similar to diabetic-obese mice and
humans, including blunted glucose-stimulate insulin release, elevated basal insulin secretion, and
low islet insulin content, which resolves by 30 weeks. Underscoring this transition is the positive
correlation between glucose-stimulated insulin release and islet insulin content. Care was taken
to select normal sized islets across all cohorts for functional assessment (~100µm in diameter)
indicating this robust improvement in β-cell functional mass is due to changes to β-cell
physiology.
Three current, non-mutually exclusive components of β-cell stress response may shed
light on the perplexing improvement in glycemic control seen in SM/J mice: β-cell
dedifferentiation, nascent β-cell maturation, and changes in β-cell subtype proportions. While
early studies concluded overworked β-cells undergo apoptosis2,325–327, recent studies have
suggested β-cells dedifferentiate into a dysfunctional, progenitor-like state, potentially as a
defense mechanisms against prolonged glycemic stress236,279,328,329. These dedifferentiated β-cells
have low insulin content and poor glucose-stimulated insulin secretion. Further, the
dedifferentiated state is reversible in cultured conditions, revealing potential for therapeutic
intervention239. It is feasible that obese SM/J mice have β-cells in the dedifferentiated state at 20weeks, which would explain the low insulin content and poor functionality despite the elevated
β-cell mass. Improvement in insulin sensitivity could ease glycemic stress, allowing
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dedifferentiated β-cells to redifferentiate by 30 weeks, reestablishing insulin production and
secretion.
Work from several groups suggests β-cells can be divided into two broad categories:
functionally immature and functionally mature cells. Immature β-cells have greater proliferative
potential and are resistant to stress, at the expense of functional maturity45,218,330. These immature
β-cells have low insulin content, high basal insulin secretion, and a lack of glucose stimulated
insulin secretion. The large β-cell expansion seen in obese SM/J mice, suggests nascent β-cells
must undergo maturation at some point. We have no evidence of enhanced β-cell replication at
20-weeks, but it is possible these β-cell are still functionally immature and reach maturity by 30weeks. This could explain why islets from these mice lack glucose stimulated insulin release,
show elevated basal insulin secretion, and have low insulin content, despite elevated mass.
Recent advances in single cell technology allows for identification of β-cell subtypes,
based on functional characteristics and gene expression. These include β-cells that specializes in
basal insulin secretion, characterized by low mature insulin content, and enriched in db/db
diabetic islets23. While these cells are not equipped to respond to elevated glucose, they are
enriched for maturity markers including Ucn3 and Glut2, distinguishing them from immature βcells. Pancreatic multipotent progenitors (PMPs) are rare insulin positive cells capable of
generating endocrine cells in vivo including functionally mature β-cells25,194. These cells
resemble immature β-cells, with low insulin content and Glut2 expression, whose proliferation is
stimulated by glycemic stress in STZ-treated and NOD mouse models. Lastly, β-cell hub cells
coordinate calcium signaling and insulin release of surrounding β-cells280. These cells have
markers for both mature and immature β-cells, including expression of Gck and Pdx1, but low
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insulin content, and are especially sensitive to glycemic and inflammatory stress. Ablation of
these cells results in loss of coordinated insulin release, suggesting they are necessary for mature
islet function. Given the elevated β-cell mass, poor insulin secretion, and low insulin content in
20-week high fat-fed SM/J mice, it is possible islets are enriched for basal insulin secretors and
PMP’s, while devoid of hub cells. At 30 weeks, as glycemic stress diminishes, basal insulin
secretors and PMP populations decline, while hub cells rise, reestablishing β-cell functionality.
Clearly, the interplay between β-cell dedifferentiation, nascent β-cell maturation, and βcell subtype identity in diabetic-obesity needs to be clarified. SM/J mice are a useful model
because they allow for appropriate comparisons across diabetic-obese, nondiabetic-obese, and
nondiabetic-lean populations. The improvement in β-cell function and increase in insulin
production in obese SM/J mice could be explained by a combination of these innate and stress
response β-cell mechanisms. Future studies interrogating how SM/J β-cells change over time will
provide insight into the physiological mechanisms that allow β-cell functionality to be
maintained and improved in the context of obesity.
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2.6 Figures and Legends

Figure 2.1. Insulin homeostasis during the resolution of hyperglycemia in obese SM/J mice.
Blood glucose levels measured after 4-hour fast from high and low fat-fed, 20- and 30-week
SM/J mice (A). Plasma insulin (B) and pancreatic insulin levels (C) assessed via insulin ELISA,
collected after 4-hour fast. Insulin tolerance test performed via intraperitoneal insulin injection
following 4-hour fast (D), summarized in the area under the curve (E). N = 38-50 mice per
cohort for panel A, C, D. N = 10-24 mice per cohort for panel B-C, equal numbers of males and
females. Bar represents group means, error bars represent SEM. *p<0.05, **p<0.01,
***p<0.001, N.S. Not Significant.
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Figure 2.2. Changes in islet mass during the resolution of hyperglycemia. Representative
pancreatic cross sections from 30-week high fat-fed mice (A) and 30-week low fat-fed mice (B)
stained for insulin (green), glucagon (white), and phosphohistone H3 (red). Dashed white box
identifies location of image in inset. Solid yellow arrows within inset identify INS+:PHH3+ cells,
dashed yellow arrow identifies GCG+:PHH3+ cell. Islet mass reported as ratio of islet cells over
total cells, summed across 4 pancreatic sections (C). Median islet area calculated for each
individual across 4 sections (D). Total number of islets quantified per individual, normalized by
total DAPI area (E). Correlation between body weight and β-cell mass in high fat-fed mice (F),
open circles – 20-week high fat-fed, filled circles – 30-week high fat-fed. N = 12-16 mice per
cohort for panels C-F, equal number of males and females. *p<0.05, **p<0.01, ***p<0.001, N.S.
Not Significant.
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Figure 2.3. Islet cell mass and mitotic index in obese SM/J mice. β-cell mass reported as ratio of
INS+ cells divided by total cells summed across 4 slides per individual (A). α-cell mass reported
as GCG+ cells divided by total cells summed across 4 slides per individual (B). β-cell mitotic
index calculated by dividing INS+:PHH3+ cells divided by total INS+ cells summed across 4
slides per individual (C). α-cell mitotic index calculated by dividing GCG+:PHH3+ cells by total
GCG+ cells summed across 4 slides (D). Correlation between β-cell mitotic index and β-cell
mass in 20 week high fat-fed mice (E) and 30-week high fat-fed mice (F). Open circles – 20week high fat-fed, filled circles – 30-week high fat-fed. N = 12-16 mice per cohort for all panels,
equal males and females. *p<0.05, **p<0.01, ***p<0.001, N.S. Not Significant.
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Figure 2.4. Islet insulin secretion and insulin content. Islet insulin secretion in response to low
(2.8 mM) and high (11mM) glucose conditions, normalized by islet insulin content (A), reported
as a ratio of high glucose to low glucose insulin secretion (B). Comparison of islet insulin
secretion under low glucose conditions in 20- and 30-week, high and low fat-fed mice (C). Islet
insulin content normalized by total protein measured via protein BCA (D). Correlation between
insulin secretion ratio and islet insulin content (E). Open circles – 20-week high fat-fed, closed
circles – 30-week high fat-fed. N = 8-19 mice per cohort for panels A-C, n = 5-11 mice per
cohort for panel D, n = 22 mice for panel E. *p<0.05, **p<0.01, ***p<0.001, N.S. Not
Significant.
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Figure 2.5. Islet area histogram (left) and density plot (right) for each cohort, 20-week high fat
(A), 30-week high fat (B), 20-week low fat (C), and 30-week low fat (D). Dashed line shows
islet size threshold. N= 2,333-10,380 islets per cohort.
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Figure 2.6. Mean β-cell area per individual. Total INS+ area divided by total INS+ cells, summed
across 4 slides per individual. N = 12-16 individuals per cohort. N.S. – Not significant.

Figure 2.7. Normalized insulin secretion in response to elevated (11 mM) glucose (A). Islet
insulin content vs glucose-stimulated insulin secretion for low fat-fed mice (B). A, N =5-14
individuals per cohort. B, N = 8. N.S. – Not significant
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2.7 Tables
Table 2.1. Cohort metrics for islet mass quantification.
Cohort
20 HF
30 HF
20 LF
30 LF
Individuals
16
16
12
11
Female /Male Ratio
0.5
0.5
0.5
0.64
Slides
62
64
48
40
Total Islets
8,320
10,380
2,333
3,141
Total Islet Area (µm²) 132,564,412 194,565,474 19,956,617 28,581,981
Avg Iset Area (µm²)
15,933
18,744
8,554
9,100
Islets/Slide
134.2
162.2
48.6
78.5
Area/Slide
2,138,136
3,040,086
415,763
714,550
Total Tissue Area (µm²) 496,461,183 512,715,812 176,863,435 198,371,139
Islet Area/Tissue Area
0.27
0.38
0.11
0.14
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Chapter 3: Identifying β-cell subpopulations and
genetic networks associated with obesity and
glycemic control in SM/J mice

By
Mario A Miranda, Juan F Macias-Velasco, Heather Schmidt, Heather A Lawson.

Adapted for dissertation from the manuscript submitted for publication and available in preprint:
Miranda MA, Macias-Velasco JF, Schmidt H, Lawson HA. Integrated transcriptomics identifies
β-cell subpopulations and genetic networks associated with obesity and glycemic control in SM/J
mice. BioRXIV. 2021 Jul 15: https://doi.org/10.1101/2021.07.15.452524
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3.1 Abstract
Understanding how heterogeneous β-cell function and stress response impact diabetic etiology is
imperative for therapy development. Standard single-cell RNA sequencing analysis illuminates
some genetic underpinnings driving heterogeneity, but new strategies are required to capture
information lost due to technical limitations. Here, we integrate pancreatic islet single-cell and
bulk RNA sequencing data to identify β-cell subpopulations based on gene expression and
characterize genetic networks associated with β-cell function in high- and low-fat fed male and
female SM/J mice at 20 and 30wks of age. Previous studies have shown that high-fat fed SM/J
mice resolve glycemic dysfunction between 20 and 30wks. We identify 4 β-cell subpopulations
associated with insulin secretion, hypoxia response, cell polarity, and stress response. Relative
proportions of these cells are influenced by age, sex, and diet. Network analysis identifies fatty
acid metabolism and β-cell physiology gene expression modules associated with the
hyperglycemic-obese state. We identify subtype-specific expression of Pdyn and Fam151a as
candidate regulators of genetic pathways associated with β-cell function in obesity. In sum, this
study uses a novel data integration method to explore how β-cells respond to obesity and
glycemic stress, helping to define the relationship between β-cell heterogeneity and diabetes, and
shedding light on novel genetic pathways with therapeutic potential.
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3.2 Introduction
Proper insulin secretion from pancreatic β-cells is required to maintain glycemic control.
Obesity initially promotes β-cell expansion, but prolonged glycemic stress and inflammation
drive β-cell death and dysfunction, resulting in type 2 diabetes2,3,241. Without sufficient β-cell
mass and insulin production, sustained hyperglycemia increases risk for deadly metabolic
diseases331–333. Currently, transplantation of cadaveric islets is the only method for restoring βcell mass in diabetes but is severely limited by donor availability and requires lifelong
immunosuppressant therapy334,335. Differentiating induced pluripotent stem cells into insulin
secreting cells may alleviate this bottleneck, but current methods fail to recapitulate fine-tuned
glucose sensing and insulin secretion in vivo336,337. There is urgent need for therapies that
improve endogenous β-cell function. This requires understanding how and why β-cells become
dysfunctional in obesity.
Improving endogenous β-cell function in diabetes is complicated by cellular
heterogeneity, because individual β-cells vary significantly in function, gene expression, protein
level, and stress response338. Single cell technologies permit interrogation of the molecular
underpinnings of heterogeneity, addressing two fundamental questions: Do functionally distinct
subpopulations of β-cells exist? Can accounting for heterogeneity improve diabetic therapy?
Several research groups have proposed subpopulations based on clustering analysis using single
cell RNA sequencing (scRNA-seq), however, there is little agreement among studies21,90,91,339.
High rates of gene dropout and low read depth contribute to these problems, necessitating
approaches that improve information capture without losing cell type-specific information102,104.
Integrating sc-RNAseq with bulk RNAseq data leverages bulk sequencing’s high read
depth, allowing for capture of lowly expressed genes and robust expression analysis. Several
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tools can integrate sc- and bulk RNA-seq data, focusing on deconvoluting bulk RNAseq data
from heterogeneous tissue to account for differences in tissue composition90,340,341. These
methods estimate and control for cell type abundance but do not identify cell type-specific
expression signatures in bulk datasets. Analytical strategies that identify cellular gene expression
signatures in bulk RNAseq data allow for robust cell type-specific differential expression
analysis and complex network analysis that is currently not feasible in scRNA-seq data.
Here, we characterize gene expression in β-cells from obese SM/J mice, who
spontaneously transition from hyperglycemic to normoglycemic with improved β-cell function
between 20 and 30 weeks of age342,343. We assign functional identities to 4 subpopulations of βcells using scRNA-seq. These subpopulations vary in proportion among hyperglycemic-obese,
normoglycemic-obese, and normoglycemic-lean mice. We identify 316 genes specifically
expressed by β-cells and establish a β-cell gene expression profile for each mouse. We leverage
this information to focus our analyses of bulk-islet RNAseq and identify β-cell-specific
differential expression and gene networks associated with the hyperglycemic-obese,
normoglycemic-obese, and normoglycemic-lean states. Two novel potential regulators of β-cell
function, Pdyn (Prodynorphin) and Fam151a (Family with sequence similarity 151 member A),
are differentially expressed, highly connected within genetic networks, and primarily expressed
by β-cell subpopulations associated with normoglycemia. This analysis demonstrates that
integrating scRNAseq with bulk RNAseq is a powerful approach for exploring β-cell
heterogeneity and identifying key genes and subpopulations that strongly associate with
glycemic state. The genetic networks and β-cell subpopulation signatures we identify have high
potential to lead to further research aimed at improving β-cell function in obesity.

55

3.3 Methods
Metabolic phenotyping. SM/J mice were obtained from The Jackson Laboratory (Bar Harbor,
ME). Mouse colony was maintained at the Washington University School of Medicine and all
experiments were approved by the Institutional Animal Care and Use Committee in accordance
with the National Institutes of Health guidelines for the care and use of laboratory animals. Mice
were weaned onto a high-fat diet (42% kcal from fat; Envigo Teklad TD88137) or isocaloric
low-fat diet (15% kcal from fat; Research Diets D12284), as previously described343. At 20 or 30
weeks of age, mice were fasted for 4 hours, body weight measured, and blood glucose was
measured via glucometer (GLUCOCARD). Mice were injected with sodium pentobarbital,
followed by a firm toe pinch to ensure unconsciousness. Blood was collected via cardiac
puncture and pancreas was collected. Blood was spun at 6000 rpm at 4°C for 20 minutes to
collect plasma. Insulin ELISA (ALPCO 80-INSMR-CH01) was used to measure plasma insulin
levels following manufacturer’s instructions.
Islet isolation and phenotyping. Islets were isolated from pancreas as previously described342 and
rested overnight. 5 Islets were equilibrated in KRBH buffer with 2.8 mM glucose for 30 minutes
at 37°C, then placed in 150 µl KRBH containing 2.8 mM glucose at 37°C for 45 minutes, then
150 µl KRBH containing 11 mM glucose at 37°C for 45 minutes. Islets were then transferred
into 150 µl acid ethanol. Islet content and secretion tubes were stored at -20°C overnight.
Experiments were performed in duplicate per individual, and measurements are reported as the
average of replicates. Mouse insulin ELISA (ALPCO 80-INSMU-E01) was performed, with the
secretion tubes diluted 1:5, and content tubes diluted 1:100. Glucose stimulated insulin secretion
was calculated by dividing insulin secretion at 11mM glucose by insulin secretion at 2.8 mM
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glucose. Basal insulin secretion was calculated by dividing insulin secretion at 2.8 mM glucose
by islet insulin content. Total islet protein was measured using Pierce BCA Protein Assay kit
(Thermo Scientific) according to manufacturer’s instructions and read at 562 nm on the Synergy
H1 Microplate Reader (Biotek). Islet insulin content was calculated by dividing the islet insulin
level in the content tubes by total islet protein. All measurements were taken in duplicate, values
reported are the average of replicates.
Single cell RNA sequencing. Single cell RNA sequencing (scRNA-seq) was performed on islets
isolated from 15 SM/J mice representing 6 cohorts: 20wk high-fat females (n=3), 20wk high-fat
males (n=3), 30wk high-fat females (n=3), 30wk high-fat males (n=2), 20wk low-fat females
(n=2), and 20wk low-fat males (n=2). Isolated islets were dissociated into single cell suspensions
using Accumax cell/tissue dissociation solution (Innovative Cell Technologies). Libraries were
prepped using the Chromium Single Cell 3ʹ GEM, Library & Gel Bead Kit v3 (10xGenomics)
and sequenced at 2x150 paired end reads using a NovaSeq S4. After sequencing, reads were demultiplexed and assigned to individual samples. Reads were aligned using 10x Genomics
CellRanger (3.1.0) against our custom SM/J reference295. Samples that were prepped together
were aggregated into batches using CellRanger aggregate. In the R environment (4.0.0), each
aggregated batch was run through SoupX (1.5.0)344 to estimate and correct for ambient RNA
contamination. A contamination fraction of 0.05 was chosen. Removal of Ins2 ambient RNA
shown in Figure 3.8D-E. Adjusted counts were imported into Seurat (3.2.2)345, where cells were
filtered for number of features detected (500-3000), total counts detected (1000-30000), percent
mitochondrial genes (0-30), visualized in Figure 3.8A. For additional quality control, we
excluded cells where nCount was not predictive of nFeature; the predictive error (residual) of a
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cell had to be within 3 standard deviations of the mean predictive error (~0). Cell counts for
samples from one batch shown before and after filtering step shown in Figure 3.8B-C.
Expression was then normalized in Seurat (normalization.method = LogNormalize), batches
were integrated, and clustered using a shared nearest neighbor approach. Using the top 10
principal components of the filtered expression data and a resolution of 0.14, we identified 9
clusters of cells using Clustree (0.4.3)346. Cell types were assigned by identifying top overexpressed genes for each cluster relative to all other clusters using a Wilcoxon rank sum test,
with an average log-fold-change threshold of >=0.25 and requiring at least 25% of cells express
the gene. Identities were assigned by comparing top over-expressed genes for each cluster with
known cell-type specific markers for islet cells.
Identification of β-cell subtypes, differential expression, and composition. All β-cells were subset
for further analysis. Using the top 10 principal components of the filtered expression data and a
resolution of 0.09 (Figure 3.8F), we identified 4 populations of β-cells, labeled Beta 1-4. Top
over expressed genes for each population were identified using a Wilcoxon rank sum test, with
an average log-fold-change threshold >= 0.1 compared to all other β-cells and an adjusted pvalue < 0.01 (Bonferroni). Subtype-identifier genes were tested for gene set enrichment (see
below) to determine presumed function of each population. Using these thresholds (average logfold-change >= 0.1 and adjusted p-value < 0.01), differential expression was calculated between
pairs of β-cell subpopulations, across all β-cells between 20wk high-fat males and 30wk high-fat
males, across all β-cells between 20wk high-fat males and 20wk low-fat males, and across Beta 1
cells between 20wk high-fat males and 20wk low-fat males using the “MAST” hurdle-model
test347. Relative proportions of β-cell subpopulations in each cohort were estimated using
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bootstrapping to calculate 95% confidence intervals by randomly sampling 1,000 cells from each
cohort for 100 iterations.
Identification of β-cell-specific genes. To identify β-cell-specific gene expression signatures in
the bulk sequencing data, we assume that for a given gene, the sum of expression in the scRNAseq data, YTotal, approximates the expression in bulk RNA sequencing data, YBulk.

The YTotal value can be re-written as the sum of expression from all the contributing cell types,
where Y is the expression from a given cell type, and N is the total number of cells of that type.
+…+
Therefore, the expected relative contribution of β-cells (Qβ-cell), to total expression (YTotal), can
be written as:

When Qβ-cell is high in all 6 cohorts, we are confident that gene expression in the bulk data is
nearly exclusively coming from β-cells. To determine the contribution of β-cells and all other
cell types to gene expression, the distribution of normalized expression was assessed using a
Cullen and Frey graph using the fitditrplus package (1.1-3)348 in R and identified as beta
distributed (Figure 3.9A-B).
scRNA-seq data is characterized by a buildup of expression values at 0 due to cells that
do not express a gene or due to gene-dropout. This distribution required us to employ a beta59

hurdle model described by three parameters: Pr(Dropout), α, and β. We treat the probability of
attaining an expression value of 0 ( Pr(Dropout) ) and the distribution of non-zero values
separately for a given gene. We fit the expression of each gene in each cell type using a betahurdle model optimized by maximum goodness of fit estimation. To fit the first part of the betahurdle mode, the Kolmogorov-Smirnov statistic using the ks.test package (4.05)349 in R was used
to select the optimal α and β shape parameters that best fit the expression distribution of nonzero-expressing cells by minimizing the distance between the cumulative distribution of the real
data and theoretical beta model data (Ks) (Figure 3.9C). To fit the second part of the beta-hurdle
mode, Pr(Dropout) was iterated between 0 and 1, selecting the Pr(Dropout) that minimized Ks
(Figure 3.9D). In most cases, assuming 100% of cells not expressing the gene was due to gene
drop out provided the best fit (Figure 3.9E). From the best fit beta-hurdle model, the expected
can be calculated using the fit α and β shape

value for each gene within a cell type
parameters as:

Multiplying the expected value by the total number of cells of that cell type provides the total
expression contribution of that cell type. Summing this value across all cell types provides total
expression and allows assessment of the contribution of β-cell gene expression to the genes’ total
expression. We required β-cells to account for >=80% of total gene expression in each of the six
cohorts analyzed, resulting in 316 “β-cell-specific genes”, shown in Table 3.2.
Bulk RNA sequencing. Islets from 32 mice were sequenced: 4 males and 4 females from each
diet (high-fat and low-fat) and each age (20wk and 30wk), n=32. Islet RNA was extracted using
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the RNeasy MinElute Cleanup kit (Qiagen), RNA concentration was measured via Nanodrop and
RNA quality/integrity was assessed with a BioAnalyzer (Agilent). Libraries were prepped using
the SMARTer cDNA synthesis kit (Takara Bio) and sequenced at 2x150 paired end reads using a
NovaSeq S4. After sequencing, reads were de-multiplexed and assigned to individual samples.
FASTQ files were trimmed and filtered to remove low quality reads and aligned against a SM/J
custom genome using STAR295,350,351. Read counts for β-cell-specific genes were normalized via
TMM normalization and pairwise differential expression between cohorts was performed using
edgeR352.
Co-expression network analysis. Weighted Gene Co-Expression Network Analysis (WGCNA)
identifies co-expression modules and correlates them with phenotypic traits353. Briefly, edgeRnormalized counts for β-cell-specific genes were converted to standard normal, and an adjacency
matrix was created from bi-weight mid-correlations calculated between all genes in all
individuals and raised to a power β of 8, chosen based on a scale-free topology index above 0.9,
to emphasize high correlations354. The blockwiseModules function created an unsigned
Topological Overlap Measure using the adjacency matrix to identify modules of highly
interconnected genes. Eigengenes were calculated as the first principal component for each
module, and Pearson’s correlations were calculated between eigengene expression and
phenotype to estimate module-trait relationships. Module-trait correlations were considered
significant at an FDR-corrected p-value < 0.05. The adjacency matrix was then used to calculate
the connectivity of each gene with other genes within its module (kwithin). Adjacency matrices
were subset for each age x diet x sex cohort, used to calculate cohort-specific connectivity for
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each gene, then used to calculate differential connectivity between cohorts. We report differential
connectivity between 20wk high-fat males and 30wk high-fat males, HM, calculated as

and differential connectivity between 20wk high-fat males and 20wk low-fat males, M20,
calculated as

where HM20, HM30, and LM20 are cohort-specific kwithin values for each gene. This provides
each gene in the comparison with a value between -1 and 1, where |kDiff| > 0.5 is considered
differentially connected. Genes with positive differential connectivity are more highly connected
in 20wk high-fat males than 30wk high-fat males or 20wk low-fat males, depending on
comparison.
Gene set enrichment analysis. Over-representation analysis (ORA) was performed using the
WEB-based Gene Set Analysis Toolkit v2019355 on genes overexpressed in individual β-cell
subtypes (Table 3.1), β-cell-specific genes (Table 3.3), and genes within blue and brown
expression modules (Table 3.4), using all genes expressed in the sc-RNAseq data set as a
reference set. Analysis included gene ontologies (biological process, cellular component,
molecular function), pathway (KEGG), and phenotype (Mammalian Phenotype Ontology).
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3.4 Results
SM/J islets contain four β-cell subpopulations. We developed an analysis pipeline that integrates
sc- and bulk RNA-seq data to characterize the transcriptional changes in β-cells from obese SM/J
mice as they improve glycemic control with age (Figure 3.1A). We identified islet cells (α, β,
and δ), exocrine cells (acinar and ductal), vascular cells (smooth muscle and endothelial), and
immune cells (B cells and macrophages) (Figure 3.1B). Subsequent clustering of β-cells
revealed 4 subpopulations, labeled Beta 1-4 (Figure 3.1C, Figure 3.8F). 20wk hyperglycemic
high-fat males have a significantly larger Beta 1 population compared to 30wk normoglycemic
high-fat males and 20wk low-fat males, at the expense of a diminished Beta 2 population
(Figure 3.1 D-E).
β-cell subpopulations have unique expression signatures. To identify genes that are
overexpressed in each subpopulation, we performed differential expression analysis between
each subpopulation and all other β-cells. The top ten highest differentially expressed genes
within each subtype are visualized in Figure 3.2. Gene enrichment analysis on the overexpressed
genes in each subpopulation reveals potential specialization: Beta 1 - insulin secretion, Beta 2 –
hypoxia response, Beta 3 – cell polarity, Beta 4 – stress response (Table 3.1).
SM/J β-cells uniquely express 316 genes. To identify genes primarily expressed by β-cells in
scRNA-seq data, we employed a beta hurdle model, which allowed us to estimate the relative
contribution of each cell type to total gene expression (Figure 3.9). To be considered a β-cellspecific gene, we required β-cells to account for at least 80% of total expression within each
cohort (Figure 3.3A). We identified 316 β-cell-specific genes (Table 3.2), comprised of genes
canonically associated with β-cell identity, including Ucn3, Gcgr, and Slc2a2 (Figure 3.3B-E)
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and genes with unknown function in β-cells (Figure 3.3F-G). Overrepresentation analysis
revealed enrichment for terms associated with β-cell function, including mature onset diabetes of
the young (MODY) and carbohydrate homeostasis, along with terms related to neuron function
including neuroactive ligand-receptor interaction, neuron projection terminus, and axon part
(Table 3.3). We then sought to discover if β-cell-specific genes were overexpressed within any
of the β-cell subpopulations. We identified 20 β-cell-specific genes overexpressed in Beta 1
cells, far more than would be expected by chance (Figure 3.3H).
β-cell genes are differentially expressed by age, diet, and sex. To robustly characterize β-cell
gene expression in SM/J mice, we normalized bulk RNA-seq data from 20- and 30-week highand low-fat males and females (4 per cohort, n=32) using only the 316 β-cell-specific genes.
Principal components analysis on the normalized expression data revealed high-fat males
separated from other cohorts (Figure 3.4A). This is consistent with our previous studies showing
that high-fat fed SM/J males show a more extreme glycemic response than other cohorts342,343.
Pairwise comparison revealed 8 differentially expressed genes between 20- and 30wk high-fat
males and 2 differentially expressed females between 20- and 30wk high-fat females (Figure
3.4B). 20wk male mice differentially express 104 genes between diets, while 30wk male mice
differentially expressed 17. Females differentially expressed a largely consistent set of genes
between diets in 20- and 30wk cohorts. We focused subsequent analyses between 20wk and
30wk high-fat males (Figure 3.4C), and 20wk high and low-fat males (Figure 3.4E). These
analyses allow comparison between hyper- and normoglycemic-obese mice, and between
hyperglycemic-obese and normoglycemic-lean mice. We highlight two genes with unknown
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roles in β-cell function, Pdyn and Fam151a, as differentially expressed between 20- and 30wk
high-fat males (Figure 3.4D), and 20wk high and low-fat males (Figure 3.4F), respectively.
β-cell gene expression networks correlate with metabolic traits. We performed network analysis
to characterize how groups of genes behaved across age and dietary cohorts. We performed
weighted gene co-expression network analysis (WGCNA), which groups similarly co-expressed
genes into discreet modules, then correlates these modules with phenotypes353. We collected
metabolic phenotypes in the bulk RNA-seq mice including body weight, blood glucose level,
serum insulin, and islet-specific phenotypes including glucose-stimulated insulin secretion, basal
insulin secretion, and islet insulin content (Figure 3.10). Performing co-expression analysis
identified 9 discreet modules of genes, 6 of which correlated significantly with at least one
phenotype (Figure 3.11). We highlight the blue and brown modules for their correlation with
phenotypes relevant to hyperglycemic obese 20wk high-fat mice.
Blue module associated with fatty acid metabolism correlates with blood glucose level and is
altered by age in obese mice. The blue module contains 42 genes, and over-representation
analysis reveals enrichment for genes related to fatty acid metabolism (Table 3.4). Blue network
eigengene expression correlates with blood glucose level across all mice (Figure 3.5A, Figure
3.12F). This correlation is driven by the resolution of hyperglycemia in high-fat mice (Figure
3.5A, Figure 3.12B). Strength of individual gene membership within the blue module correlates
with strength of correlation to blood glucose levels (Figure 3.5B). The blue network is
visualized as the sum of gene-pair correlations (Figure 3.12D). This network was then subset
into 20wk high-fat males (Figure 3.5D) and 30wk high-fat males (Figure 3.5E). Four genes
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were identified as differentially connected between networks, although none were individually
differentially expressed between 20- and 30wk high-fat males (Figure 3.5C).
Brown module associated with β-cell function correlates with insulin levels and is influenced by
diet. The brown module contains 39 genes, and over-representation analysis reveals enrichment
for genes related to abnormal β-cell physiology (Table 3.4). Brown network eigengene
expression negatively correlates with serum insulin levels across all mice (Figure 3.6A, Figure
3.12E). This correlation is driven in part by diet, where high-fat mice have high levels of
circulating insulin (Figure 3.6A, Figure 3.12A). Strength of gene membership in the brown
module negatively correlates with strength of correlation to serum insulin level, including
Fam151a, which is highly connected in the brown network (Figure 3.6B). Further, expression of
Fam151a negatively correlates with serum insulin levels across all cohorts, independent of
network construction (Figure 3.6C). The brown network is visualized as the sum of gene-pair
correlations (Figure 3.12C). The network was subset into 20wk high-fat males (Figure 3.6D)
and 20wk low-fat males (Figure 3.5E), revealing strong network structure in 20wk low-fat
males. Differential connectivity was calculated between 20wk high and low-fat males to identify
genetic network connectivity that was altered between cohorts (Figure 3.6F). Differential
connectivity was contrasted with differential expression between 20wk high and low-fat males,
revealing Fam151a to be both differentially connected and differentially expressed (Figure
3.6G).
Single cell expression of Pdyn and Fam151a are influenced by age and diet. We sought to
determine if the differential expression of Pdyn and Fam151a seen in the bulk analysis is
recapitulated at the single cell level. We compared expression of Pdyn in all β-cells between
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20wk high-fat males and 30wk high-fat males (Figure 3.7A) and found significant differential
expression, driven by differences in the proportion of β-cells expressing Pdyn (Figure 3.7B).
Likewise, Fam151a is differentially expressed across all β-cells between 20wk high-fat males
and 20wk low-fat males (Figure 3.7C), driven by differences in the proportion of β-cells
expressing Fam151a (Figure 3.7D). To determine if differential expression could be attributed
to changes in β-cell subpopulation proportions, we calculated differential expression between the
two most prominent subtypes, Beta 1 and Beta 2, revealing significant differential expression of
Pdyn and Fam151a (Figure 3.7E). While Pdyn is overexpressed in Beta 2 cells, which are
prominent in 30wk high-fat males, Fam151a is overexpressed in Beta 1 cells, which are
prominent in 20wk high-fat males. This suggests differential expression of Pdyn can be
attributed to differences in subpopulation proportions, but not for differential expression of
Fam151a. Assessing differential expression in Beta 1 cells between 20wk high-fat males and
20wk low-fat males revealed Fam151a was very significantly differently expressed (Figure
3.7F), driven by an increase in the proportion of β-cells expressing Fam151a (Figure 3.7G),
which could contribute to the differential expression of Fam151a between 20wk high-fat males
and 20wk low-fat males seen in the bulk data.
3.5 Discussion
Pancreatic β-cell heterogeneity has been studied extensively using single cell technology
because of the cell type’s unique insulin-secreting capabilities and central role in diabetes
etiology. Several groups have proposed the existence of functionally distinct β-cell
subpopulations24,25,45,356, but their existence and relevance to insulin homeostasis remain
controversial. We identified 4 β-cell populations (Figure 3.1-3.2, Figure 3.8), Beta 1-4, across
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hyperglycemic-obese, normoglycemic-obese, and normoglycemic-lean mice. While the
functional roles assigned to each population are based on gene enrichment analysis and open to
interpretation (Table 3.1), the relative proportion of each population changes in conjunction with
islet function across cohorts, suggesting a functional relevance to overall β-cell population
structure.
Beta 1 cells are most prevalent in hyperglycemic obese mice and are associated with
elevated basal insulin secretion and low insulin content. Beta 1 cells overexpress mature markers
including Ucn3357, Pdx1246, and Acly358, and negative regulators of glucose-stimulated insulin
secretion including Abcc8359, G6pc2360, and Ucp2361. Terms associated with Beta 1 cells include
signal release and hormone transport. Beta 1 cells appear to be primed for insulin release, but not
to perform glucose-stimulated insulin secretion. Farack et al356 identified a subpopulation of
“extreme” β-cells that specialize in basal insulin secretion, with high insulin expression and low
mature insulin content. These cells have high expression of markers Ucn3, Acly, and Pdx1, and
increase in proportion in obese mice. The Beta 1 cells we identified are similar to “extreme” βcells based on their mature profile, potentially limited glucose response, and abundance in
diabetic obese mice. Validation is required to determine if these β-cells function by overexpressing insulin secretion pathway components while suppressing glucose response
mechanisms.
Beta 2 cells are prevalent in normoglycemic-obese and normoglycemic-lean mice and are
associated with high GSIS and high islet insulin content. Beta 2 cells are enriched for response to
oxygen levels, pyruvate metabolism, and nucleotide phosphorylation, each associated with
protection from hypoxia362,363. These cells are equally prevalent in obese 30wk high-fat males
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and lean 20wk low-fat males, which differ greatly in islet mass, suggesting Beta 2 cells are not a
hypoxic population. Further, 20wk high-fat males have similar islet mass to 30wk high-fat males,
but a much smaller Beta 2 population. Importantly, 30wk high-fat males have healthier glycemic
parameters than 20wk high-fat males342,343. Several groups have identified a subset of heavily
vascularized islets that have elevated oxygen consumption and superior GSIS at the cost of
susceptibility to hypoxia. We suspect Beta 2 cells represent a highly functional β-cell population
that confer protection against hypoxia154,156. Given their abundance in functional islets from both
obese and lean normoglycemic mice, we hypothesize Beta 2 cells represent a mature, and
possibly stress-resistant β-cell population.
Beta 3 cells are prevalent in normoglycemic obese mice which have elevated β-cell mass,
high GSIS, and high insulin content. Beta 3 cells overexpress plasma membrane components,
including several claudin family members, and ribosome components. Claudins provide
structural integrity to tight junctions, which maintain cell polarity364. Polarity in β-cells serves as
both a driver and a characteristic of mature, highly functional β-cells43,45,365. Cldn4, Cldn3, and
Cldn7 are all upregulated in Beta 3 cells and associated with mature β-cell function366. Beta 3
cells upregulate 7 ribosome genes and elevated ribosome biogenesis is associated with increased
β-cell apoptosis367, β-cell replication45, and mature β-cell function368, making the functional
relevance of overexpression unclear. One gene, Rpl7, is associated with mature β-cell
function369, while Rpl23 protects against apoptosis370. From this we conclude that Beta 3 cells
represent a polarized and mature β-cell population.
Beta 4 cells are the lowest in abundance and elevated in lean males compared to obese
males. Terms associated with Beta 4 cells include response to stress and response to
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topologically incorrect protein. In addition to overexpression of UPR components, Beta 4 cells
have significant down regulation of Ins1 and Ucn3. Several groups have identified β-cell
subpopulations based on a stress response signature91,92,371, which have coalesced into a theory
about stress response cycling, where β-cells go through periods of UPR activation and low
insulin production to clear misfolded proteins21,259. Interestingly, 20wk low-fat mice have a
similar proportion of stress response cycling cells compared to other groups (~7%), however this
population is significantly smaller in high-fat males, suggesting that stress response cycling may
be suppressed by obesity.
Efforts to describe β-cell transcriptional heterogeneity are marred by lack of consensus
across scRNA-seq studies372. This is attributed to low read depth, which results in differences in
gene capture driven by technical artifacts and random chance rather than biological variation102.
Further, it is unclear what level of gene expression fold change is meaningful between individual
cells, rendering single cell data poorly suited to assess differential expression across different
cohorts. To address these problems, we developed a technique to integrate single cell data with
bulk RNA-seq data (Figure 3.3, Figure 3.9), which is not inhibited by these technical
limitations, to assess β-cell-specific differential expression across cohorts of high- and low-fat
fed male and female SM/J mice. While the list of genes identified as β-cell-specific is only 316
genes (Table 3.2), we are highly confident of their specificity to β-cells, allowing for robust
assessment of differential expression and network analysis. Sub-setting the bulk RNA-seq data
by β-cell-specific genes provided a small but highly-focused search space to identify genes that
influence β-cell function in hyperglycemic-obesity, normoglycemic-obesity, and healthy mice.
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We identified Pdyn as a novel candidate gene associated with improved glycemic control
in males. Pdyn encodes Proenkephalin-b, which is cleaved into dynorphin A and dynorphin B,
and exert effects through the κ-opioid receptor373. While Pdyn’s role in β-cell function is
unknown, activation of the κ-opioid receptor reduces hyperglycemia in diabetic mice and β-cells
secrete dynorphin A in a glucose-dependent manner374,375. Further, Pdyn expression is associated
with regulation by Pax6 and Lkb1, hallmarks of mature β-cells376,377. Pdyn is over expressed in
Beta 2 cells, which are increased in normoglycemic-obese mice, and may link improved β-cell
function with hypoxia response, as Pdyn provides protection from hypoxia in lung and neuronal
tissue378,379.
We used weighted gene co-expression network analysis (WGCNA) to identify networks
of co-expressed β-cell genes and to assess how networks correlate with metabolic and islet
phenotypes (Figure 3.10). Previous efforts to construct networks in islet RNA-seq data failed to
account for cell-type specific gene expression, making it difficult to determine if these networks
operate within an individual cell380–382. Our analysis revealed 6 β-cell-specific modules that
correlate with phenotypes, two of which were enriched for intriguing ontology terms (Figure
3.11). We chose to explore these networks in depth to assess the context in which they were
relevant to β-cell function in obesity.
The blue module is highly expressed in 20wk high-fat males, strongly correlating with
blood glucose concentration (Figure 3.5, Figure 3.12). The blue module is enriched with fatty
acid metabolism genes, which are heavily implicated in obesity and diabetes (Table 3.4). In βcells, fatty acid metabolism provides a glucose-independent stimulus for insulin release383,384.
While short term fatty acid exposure enhances GSIS, prolonged exposure decreases GSIS and
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reduces insulin content383,385. Fatty acid metabolism protects against glucotoxicity-induced
damage, allowing cells to convert excess glucose into glycerol, which bypasses ROS
generation386. How this network connects to the β-cell dysfunction seen in obese, hyperglycemic
20wk high-fat mice is not immediately clear. Since fatty acid metabolism can stimulate insulin
release, it is possible that prolonged activation of this network promotes elevated basal insulin
secretion but inhibits GSIS. Expression of this network may be related to the abundance of Beta
1 cells in 20k high-fat males, which are geared toward basal insulin release. One gene in the blue
module, Entpd3, confers susceptibility to diet-induced obesity and hyperglycemia387. This fatty
acid metabolism gene network may provide a link between the increased proportion of Beta 1
cells and the β-cell dysfunction observed in 20wk high-fat males.
The brown module is highly expressed in lean mice and negatively correlates with serum
insulin levels (Figure 3.6, Figure 3.12). Unsurprisingly, this module is enriched for genes
associated with β-cell physiology (Table 3.4). We focused on how the network behaved in 20wk
high and low-fat males, as they provided strong contrast for serum insulin levels and β-cell
function. Core members of this network include known markers of β-cell maturation including
Ucn3, Slc2a2, and Pcsk1. This network is suppressed in 20wk high-fat males, who have
dysfunctional β-cells. We homed in on Fam151a, a gene highly connected within the network,
that independently correlates with serum insulin levels. Fam151a is both differentially expressed
and differentially connected within the brown module between 20wk high-fat and 20wk low-fat
mice, suggesting an important role within the network and a potential link between serum insulin
levels and β-cell function. Fam151a is a membrane embedded protein of unknown function, but
it has been associated with dysregulated insulin secretion in Isl1 knockout mice, and falls within
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a QTL associated with diabetes388–390. Further work will explore how Fam151a influences β-cell
function in the context of obesity.
We explored if subpopulation composition contributes to differential expression of Pdyn
and Fam151a (Figure 3.7). Total Pdyn expression increased across all β-cells between 20 and
30wk high-fat fed males, in agreement with the bulk RNA-seq data. Pdyn is overexpressed in
Beta 2 cells, which increase in proportion between 20 and 30 weeks in high-fat mice, suggesting
differential expression of Pdyn is driven by a change in subpopulation proportions. Investigation
into how Pdyn influences in β-cell function must consider that knockout/overexpression may
affect subpopulations differently, and that subpopulation structure changes based on metabolic
context. Likewise, total Fam151a increased across all β-cells between 20wk high and low-fat
males, in agreement with the bulk RNA-seq data. However, Fam151a is strongly overexpressed
in Beta 1 cells, which are most abundant in 20wk high-fat males. To explore this discrepancy, we
performed differential expression analysis in Beta 1 cells between 20wk high and 20wk low-fat
males and found Fam151a expression is significantly higher in 20wk low-fat male Beta 1 cells.
Thus, while the proportion of Beta 1 cells is lower in 20wk low-fat mice, the expression of
Fam151a is significantly increased in their Beta 1 cells. These findings underscore the
complexity of gene expression and suggest it is important to consider both subpopulation
composition and expression within subpopulations when exploring β-cell heterogeneity in
diabetes and obesity.
In summary, we identified 4 β-cell subpopulations whose relative proportions change
depending on metabolic state. Beta 1 cells are primed for basal insulin secretion and
proportionally high in hyperglycemic obese mice. Beta 2 cells are primed for protection from
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hypoxia associated with enhanced function and are abundant in normoglycemic obese and
normoglycemic lean mice at the expense of Beta 1 cells. In conjunction, hyperglycemic obese
mice express a highly connected genetic network associated with fatty acid metabolism, which is
lost as glycemic control improves. The interplay between changing β-cell subpopulations and
decreased fatty acid metabolism likely contributes to the improved β-cell function and
subsequent restoration of glycemic control seen in obese SM/J mice342,343. This study provides a
road map for exploring cellular heterogeneity by integrating sc- and bulk RNA-seq data,
allowing for robust characterization of subpopulation structure, differential expression, and
network analysis associated with obesity and glycemic stress.
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3.6 Figures and Legends

Figure 3.1. SM/J islets contain four subpopulations of β-cells. (A) Data analysis pipeline
identifies subpopulations of β-cells and integrates bulk and single cell RNA sequencing data. (B)
Single cell RNA sequencing UMAP plot of islet tissue. VSMC – vascular smooth muscle cell,
VEC – vascular endothelial cell. (C) Single cell RNA sequencing UMAP of 4 subpopulations of
β-cells. (D) Bootstrap analysis quantifies relative proportions of β-cell subpopulations across
cohorts. Black dot represents estimated proportion, colored bars illustrate 95% confidence
interval. Cell type composition estimates with non-overlapping confidence intervals are
significantly different. (E) Ternary plot illustrates differences in subtype composition of Beta 1-3
in high-fat SM/J mice. HF20 – 20wk high-fat female, HF30 – 30wk high-fat female, HM20 –
20wk high-fat male, HM30 – 30wk high-fat male, LF20 – 20wk low-fat female, LM20 – 20wk
low-fat male.
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Figure 3.2. β-cell subpopulations have unique gene expression signatures. (A) Heat map for top
10 differentially expressed genes in each β-cell subpopulation. Yellow is highly expressed;
purple is lowly expressed.
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Figure 3.3. Single cell RNA sequencing identifies β-cell-specific genes. (A) Total gene
expression and β-cell-specific contribution to gene expression in 20wk low-fat female β-cells.
Gold line indicates threshold for β-cell-specific expression. Red dots identify genes that pass the
threshold cutoff in this cohort. Arrows identify highly expressed genes associated with β-cell
identity. Genes must pass threshold in all cohorts to be considered β-cell-specific in the rest of
the analysis. (B) UMAP plot of all islet cell types. UMAP plots for β-cell-specific expression of
known β-cell markers (C) Ucn3, (D) Gcgr, (E) Slc2a2. UMAP plots for β-cell-specific
expression of novel β-cell markers (F) Pdyn, and (G) Fam151a. (H) Permutation analysis of βcell-specific genes in Beta 1 overexpressed genes. Distribution shows expected number of β-cellspecific genes in Beta 1 overexpressed gene set based on chance (n = 1000 permutations), red
line indicates number of β-cell-specific genes in Beta 1 overexpressed gene set. P-value indicates
probability of number of β-cell-specific genes in Beta 1 overexpressed gene set due to chance.
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Figure 3.4. β-cell-specific genes are differentially expressed by age, diet, and sex. (A) Principal
component analysis of bulk RNA sequencing data normalized with only β-cell-specific genes.
(B) Number of differentially expressed genes in females and males, across diets and age. (C)
Differentially expressed genes between 20wk high-fat males and 30wk high-fat males. (D) Pdyn
is differentially expressed in high-fat males. (E) Differentially expressed genes between 20wk
high-fat males and 20wk low-fat males. (F) Fam151a is differentially expressed in 20wk males.
Blue genes are significantly under-expressed in comparison, red genes are significantly overexpressed. Vertical golden lines indicate threshold for significance based on average log fold
change, horizontal line indicates threshold for significance based on FDR corrected p-value. **pvalue <0.01, **** p-value < 0.0001 in FDR corrected pairwise comparison. HF20 – 20wk highfat female, HF30 – 30wk high-fat female, HM20 – 20wk high-fat male, HM30 – 30wk high-fat
male, LF20 – 20wk low-fat female, LM20 – 20wk low-fat male.
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Figure 3.5. Blue modules network structure is altered by age in high-fat male mice. (A) Blue
module heatmap, eigengene expression, and blood glucose levels across all individuals. (B)
Correlation between strength of module membership and blood glucose levels for blue module.
(C) Total and differential connectivity between blue module genes in 20wk and 30wk high-fat
male mice. Vertical golden lines indicate threshold for differential connectivity. (D) Blue module
network structure in 20wk high-fat males and (E) 30wk high-fat males. Size and color of node
indicates overall connectivity within the network, thickness of edges indicates strength of
correlation between gene pairs.
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Figure 3.6. Brown module network structure is altered by diet in 20wk male mice. (A) Brown
module heatmap, eigengene expression, and insulin levels across all individuals. (B) Correlation
between strength of module membership and serum insulin levels for brown module. Gene of
interest, Fam151a, is highlighted. (C) Expression of Fam151a correlates with serum insulin
levels across all individuals independent of module membership. Light red – 20wk high-fat mice,
dark red – 30wk high-fat mice, light blue – 20wk low-fat mice, dark blue – 30wk low-fat fed
mice. (D) Brown module network in 20wk high-fat males and (E) 20wk low-fat males. Gene of
interest, Fam151a, is highlighted in yellow. Size and color of node indicates connectivity within
the network, edge thickness indicates strength of correlation between gene pairs. (F) Total and
differential connectivity between brown module genes in high and low-fat male SM/J mice.
Vertical golden lines indicate threshold for significant differential connectivity. Gene of interest,
Fam151a, is highlighted. (G) Differential connectivity and differential expression of brown
module genes between 20wk high and 20wk low-fat males. Vertical golden lines indicate
threshold for differential connectivity, Horizontal golden line indicates threshold for differential
expression. Gene of interest, Fam151a, is highlighted.
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Figure 3.7. Pdyn and Fam151a are differentially expressed in β-cell subtypes. (A) Expression of
β-cell-specific genes across all β-cells between 20wk and 30wk high-fat males. (B) Percent of βcells in 20wk and 30wk high-fat males expressing β-cell-specific genes. (C) Expression of βcell-specific genes across all β-cells between 20wk high and low-fat males. (D) Percent of β-cells
in 20wk high and low-fat males expressing β-cell-specific genes. (E) Comparison of Pdyn and
Fam151a expression across β-cell subtypes. (F) Expression of β-cell-specific genes in beta 1
cells between 20wk high-fat and 20wk low-fat fed mice. (G) Precent of beta 1 cells expressing
beta specific genes between 20wk high-fat and 20wk low-fat fed mice. Blue genes are
significantly under-expressed in comparison, red genes are significantly over-expressed. Vertical
golden lines indicate threshold for significance based on average log fold change, horizontal line
indicates threshold for significance based on Bonferroni corrected p-value.
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Figure 3.8. Single cell RNA sequencing quality control. (A) Total counts, features, and
mitochondrial RNA expression plotted for each cell. Cells within blue box and without
mitochondrial gene expression were included in analysis. (B) Number of cells identified in
individual mice prior to quality control, (C) and after quality control. (D) Expression of Ins2
across all cells prior to ambient RNA removing using SoupX, (E) and after ambient RNA
removal. (F) Resolution analysis to determine the number of β-cell subpopulations. Selected
resolution highlighted with red box.
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Figure 3.9. Quantifying expected expression for β-cell expression of Dcd. (A) Distribution of
expression across all β-cells. (B) Cullen and Frey analysis identifies Dcd expression to be beta
distributed. (C) Kolmogorov-Smirnov test identifies alpha and beta parameters that minimize Ks
between real (blue line) and simulated (red line) distribution of cells expressing Dcd. (D)
Estimating percent of cells not expressing Dcd due to gene drop out by iterating alpha and beta
parameters that minimize Ks between real and simulated data. (E) Density plot visualizing
estimated parameters for distribution of Dcd expression. Red line shows distribution of actual
data, black line shows distribution of simulated data based on optimal alpha and beta parameters.
From these parameters, expected expression is calculated.
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Figure 3.10. Metabolic and islet phenotypes from bulk RNA sequencing mice. (A) body weight,
(B) blood glucose, (C) serum insulin levels collected after 4-hour fast. (D) Glucose-stimulated
insulin secretion (GSIS), (E) Basal insulin secretion, (F) Islet insulin content collected after
isolated islets were rested overnight. N = 4 mice per age X sex X diet cohort. N= 10 islets per
individual for islet phenotypes. Middle bar represents mean, box represents 25th and 75th quartile,
whiskers represent minimum and maximum values.
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Figure 3.11. Correlation between phenotype and module eigengene expression. Number of
genes within each module reported on y-axis, phenotypic trait reported on x-axis. For each
module-trait relationship, the Pearson correlation between eigengene expression and phenotype
value is reported (top) along with an FDR-corrected p-value for the correlation (bottom). Color
of box indicates strength of correlation. NS = non-significant association based on FRDcorrected p-value.
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Figure 3.12. Overview of brown and blue modules. (A) Principal component analysis of gene
expression within the brown module across all cohorts, segregated by diet. (B) Principal
component analysis of gene expression within the blue module, segregated by cohort. (C) Brown
module network structure in across all cohorts. Gene of interest, Fam151a, is highlighted in
yellow. Size and color of node indicates overall connectivity within the network, thickness of
edges indicates strength of correlation between gene pairs. (D) Blue module network structure in
across all cohorts. Size and color of node indicates overall connectivity within the network,
thickness of edges indicates strength of correlation between gene pairs. (E) Correlation between
brown module eigengene expression and serum insulin levels across all cohorts. (F) Correlation
between blue module eigengene expression and blood glucose levels across cohorts.
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3.7 Tables
Table 3.1. Top five results for over-representation analysis (ORA) on significantly enriched
genes within each β-cell subpopulation, including gene ontology terms.
Gene Set

Description
Beta 1

GO:0023061
GO:0009914
GO:0030133
GO:0019932
GO:0033500

signal release
hormone transport
transport vesicle
second-messenger-mediated signaling
carbohydrate homeostasis
Beta 2
response to oxygen levels
pyruvate metabolic process
nucleotide phosphorylation
nucleoside diphosphate metabolic process
generation of precursor metabolites and energy
Beta 3
apicolateral plasma membrane
structural constituent of ribosome
ribosome
cytosolic part
extracellular matrix
Beta 4
regulation of DNA-templated transcription in response to stress
negative regulation of growth
response to topologically incorrect protein
response to starvation
response to ketone

GO:0070482
GO:0006090
GO:0046939
GO:0009132
GO:0006091
GO:0016327
GO:0003735
GO:0005840
GO:0044445
GO:0031012
GO:0043620
GO:0045926
GO:0035966
GO:0042594
GO:1901654

87

Ratio

FDR

4.60
6.89E-13
4.72
3.23E-09
3.90
3.45E-07
4.34
3.45E-07
3.89 0.000044254
5.49
10.55
10.45
8.84
4.53

7.22E-08
6.13E-07
2.3329E-06
2.5493E-06
3.3401E-06

31.35
7.90
5.42
5.42
4.66

0.0042583
0.0042583
0.02957
0.02957
0.02957

37.35 0.00021552
12.11 0.0044405
16.41 0.0044405
11.63 0.017622
11.33 0.094767

Table 3.2. β-cell-specific genes identified in single cell RNA sequencing analysis.
Gene ID
0610009E02Rik

Bace2

Dapl1

Gcgr

Il17re

Mrgpre

Qpct

Tenm3

1700084C01Rik

Barhl1

Defb1

Gdf11

Impg2

Mrm1

Rasgrf1

Th

1810019D21Rik

BC017158

Dennd6b

Gdpgp1

Inpp5j

Mt3

Rbm20

Thrsp

1810059H22Rik

BC051226

Dgke

Ggt7

Ins1

Mtmr10

Rec8

Tmem121

2210404J11Rik

Bdh1

Dgkg

Gipr

Ins2

Mtss1l

Rhbdl2

Tmem150c

2900005J15Rik

Brsk1

Diras2

Gjd2

Insrr

Naaa

Rhd

Tmem180

A330050F15Rik

Brsk2

Dis3l

Glb1l2

Intu

Nars2

Rims3

Tmem215

Dmpk

Glt1d1

Rit2

Tmem231

A830039N20Rik C030014I23Rik

Isoc2b Nckap5

A930011G23Rik

C1rl

Dner

Glt28d2

Jag2

Ndrg4

Rnf182

Trmt61b

Abcb4

C2cd4a

Dnmt3b

Gm10075

Jph4

Nkx6-1

Rnls

Trpm5

Abcb6

C2cd4c

Dolpp1

Gm10567 Kcnb2

Dusp23

Nrcam RP24-510G5.4

Ttc26

Abhd15

C330027C09Rik

Gm10941 Kcnh1

Nrip3

Rps6kc1

Tti2

AC102739.1

Car10

E130317F20Rik Gm11789 Kcnh6

Nupl1

Rpusd1

Ttyh1

AC130216.1

Cartpt

E530001K10Rik Gm1631

Nyap2

Rtkn2

Tubb3

AC131780.1

Casr

Efna5

Gm17538 Kctd15 Osbpl7

Rtn4ip1

Ucn3

Acot11

Ccbl1

Eme2

Gm5105

Kdm1b

Otub2

S100a9

Ufsp1

Acpl2

Ccdc149

Enthd2

Gm5860

Kif19a

Ovol2

Sap130

Ush2a

Acsl6

Ccdc162

Entpd3

Gp1bb

Klhl8

P2ry1

Scel

Utp14b

Acss2

Ccl28

Erc2

Gpr158

Kpna2

Pan2

Sec16b

Vgf

Adh1

Cdh4

Esrrg

Gramd1c

Ky

Papss2

Sgcz

Vps37c

Adora1

Cdh8

Exog

Grem2

Lgi1

Pcsk1

Shisa2

Vstm2l

Kcnip1

Adra2a

Cecr5

Fam151a

Grin1

Lhx1

Pcsk4

Six4

Wdr25

Akr1c14

Cep135

Fam160a1

Grip1

Lphn3

Pde4a

Slc16a9

Whrn

Akr1e1

Cep76

Fam179a

Gstm4

Lrrc16b Pde5a

Slc25a35

Xpo5

Aldh1l2

Cep85

Fam217b

Gtf2e1

Lrrtm2

Pdyn

Slc25a40

Xrcc3

Amigo3

Cep97

Fbxo16

Gucy2c

Mapt

Pemt

Slc2a13

Zbtb48

Mccc2

Pgap3

Amph

Cmbl

Ffar3

Hapln4

Slc2a2

Zc3h3

Angel1

Cnnm1

Fhdc1

Helq

Mcph1 Pitpnm3

Slc35d3

Zdhhc24

Hhat

Meig1

Angptl7

Cntfr

Fig4

Plch1

Slc4a10

Zfp174

Ankrd27

Cntn1

Flrt1

Hist1h1d Mettl7a1 Pnpla3

Slc5a6

Zfp324

Ankrd49

Cox6a2

Fmo1

Hist1h4i

Poc5

Slc9a9

Zfp346

Ap3m2

Cpne4

Fras1

Hist2h2bb Mfsd8

Poll

Slco1a6

Zfp518b

Ap4b1

Crocc

Frmd5

Hist2h3c2 Mlxipl

Pou6f1

Smoc1

Zfp692

Apba1

Csn3

Fut1

Hist2h4

Mmp24 Ppm1e

Snx25

Zfp758

Aqp4

Cst6

Fut4

Hlcs

Mns1

Ppp1r1a

Srrm4

Zfp839

Ascl1

Cyb561d1

G6pc2

Hmgcll1

Mnx1

Ppp1r42

St8sia1

Zscan22

Asic1

Cyp7b1

Gabbr2

Hps5

Mon1b

Prlr

St8sia5

Atg4c

D3Bwg0562e

Gad1

Hs3st6

Morn4

Prrt1

Tat

Galnt14

Hspa12a

Mpp3

Prss53

Tcaim

Galnt9

Ica1l

Mpz

Pyroxd2

Tctn3

B230216N24Rik D630045J12Rik
B3galt4

Dagla
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Mfsd6l

Table 3.3. Top five results for over-representation analysis (ORA) for β-cell-specific genes,
including gene ontology and mammalian phenotype ontology terms.

Gene Set
mmu04950
mmu04080
GO:0044306
GO:0033500
GO:0033267

Description
Maturity onset diabetes of the young
Neuroactive ligand-receptor interaction
neuron projection terminus
carbohydrate homeostasis
axon part

Ratio
8.38
5.05
3.97
3.19
2.48

FDR
0.0808
0.0808
0.0808
0.0808
0.0808

Table 3.4. Type five results for over-representation analysis (ORA) on genes within brown and
blue modules, including gene ontology and KEGG pathway terms.
Gene Set
MP:0003562
MP:0010147
MP:0003059
MP:0004994
MP:0002693
mmu00072
mmu00601
mmu00650
mmu04976
mmu01100

Description
Brown Module
abnormal pancreatic beta cell physiology
abnormal endocrine pancreas physiology
decreased insulin secretion
abnormal brain wave pattern
abnormal pancreas physiology
Blue Module
Synthesis and degradation of ketone bodies
Glycosphingolipid biosynthesis
Butanoate metabolism
Bile secretion
Metabolic pathways
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Ratio

FDR

12.34
11.99
15.64
24.60
8.36

0.1381
0.1381
0.2031
0.2942
0.2942

72.44
39.01
31.69
14.91
2.11

0.0964
0.1765
0.1798
0.6046
1.0000

Chapter 4: Conclusions and Future Directions

By
Mario A Miranda

90

4.1 Summary
Pancreatic β-cells are optimized to secrete insulin, a process critical for maintaining
appropriate blood glucose concentration. In type 2 diabetes, peripheral insulin resistance
promotes initial β-cell expansion, but ultimately results in β-cell death and dysfunction2–4.
Obesity raises the risk of developing type 2 diabetes 27-76 fold, while approximately 60% of
individuals with diabetes are obese268–271. Despite the stress obesity places on β-cells, 10-30% of
obese individuals maintain glycemic control and are at low risk for developing diabetes276. These
low-risk obese individuals have elevated β-cell mass and improved insulin secretion compared to
BMI-matched diabetic-obese individuals2,13,277,278. Understanding the differences in β-cell
physiology between these populations may reveal therapeutic strategies for maintaining and
improving glycemic control in obese individuals.
Like in humans, diabetic risk in obese mice depends on genetic background281–284. Variation
in β-cell heterogeneity likely underlies variability in islet stress response, and thus needs to be
accounted for when comparing nondiabetic-obese and diabetic-obese populations. No current
mouse model is well-suited to examine physiological differences in β-cell health between
nondiabetic-obese and diabetic-obese states. Cell sorting, imaging, and sequencing technologies
have allowed for analysis of multiple β-cell properties, revealing that β-cells vary in morphology,
function, and gene expression. The importance of heterogeneity is reinforced by observations
that β-cells are subject to variable fates in diabetes including apoptosis, replication, and
dedifferentiation2,26–28. Characterization of β-cell heterogeneity has led to questions about its role
in diabetic etiology and therapy29. Examining heterogeneity lends itself to questions about the
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applications and limitations of β-cell plasticity, which can focus research aimed at improving βcell function.
The SM/J inbred mouse strain has been used to study interactions between diet and
metabolism, and more recently has uncovered genetic architecture underlying diet-induced
obesity and glucose homeostasis290–295. After 20 weeks on a high fat diet, SM/J mice display
characteristics of diabetic-obese mice, including elevated adiposity, hyperglycemia, and glucose
intolerance296. We have previously shown that by 30 weeks of age, high fat-fed SM/J mice enter
diabetic remission, characterized by normalized fasting blood glucose, and greatly improved
glucose tolerance and insulin sensitivity297. Given the central role of β-cell health in
susceptibility to diabetic-obesity, we hypothesize that obese SM/J mice undergo restoration of
functional β-cell mass during the resolution of hyperglycemia. By contrasting β-cells in
hyperglycemic-obese and normoglycemic-obese. Given the increasing relevance of β-cell
heterogeneity in diabetes research, we also sought to characterize β-cell subpopulations in obese
SM/J mice, and how they contribute to the hyper- and normoglycemic-obese states. By
integrating phenotypic information with subpopulation structure, a more complete picture of βcell function in obese SM/J mice can be achieved.
In chapter 2, we determined that increased insulin production and insulin sensitivity
accompany improved glycemic control, driven by expanded β-cell mass and improved glucosestimulated insulin secretion. To our knowledge, this is the first report of improved β-cell
function in an obese inbred strain. β-cell hyperplasia is the primary driver of islet expansion in
mouse models of obesity287,288. Some nondiabetic obese mice experience increased β-cell
number, but do not show evidence for elevated β-cell replication in immunostaining of
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pancreatic sections282,315. This has been attributed to technical artifacts in sampling could result
in inflated variances which mask biological differences. This could be the case here, given that
high fat-fed SM/J’s β-cell number is far above low fat-fed controls, that their β-cell number
expands 2-fold during the resolution of hyperglycemia, yet we find no evidence for increased βcell replication. 20-week high fat-fed SM/J mice have an insulin secretion profile similar to
diabetic-obese mice and humans, including blunted glucose-stimulate insulin release, elevated
basal insulin secretion, and low islet insulin content, which resolves by 30 weeks.
Three components of β-cell stress response may shed light on the perplexing
improvement in glycemic control seen in SM/J mice: β-cell dedifferentiation, nascent β-cell
maturation, and changes in β-cell subtype proportions. While early studies concluded
overworked β-cells undergo apoptosis2,325–327, recent studies have suggested β-cells
dedifferentiate into a dysfunctional, progenitor-like state, potentially as a defense mechanisms
against prolonged glycemic stress236,279,328,329. These dedifferentiated β-cells have low insulin
content and poor glucose-stimulated insulin secretion. Further, the dedifferentiated state is
reversible in cultured conditions, revealing potential for therapeutic intervention239. It is feasible
that obese SM/J mice have β-cells in the dedifferentiated state at 20-weeks, which would explain
the low insulin content and poor functionality despite the elevated β-cell mass. Improvement in
insulin sensitivity could ease glycemic stress, allowing dedifferentiated β-cells to redifferentiate
by 30 weeks, reestablishing insulin production and secretion.
Recent advances in single cell technology allows for identification of β-cell subtypes,
based on functional characteristics and gene expression. Integrating sc-RNAseq with bulk
RNAseq data leverages bulk sequencing’s high read depth, allowing for capture of lowly
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expressed genes and robust expression analysis. Several tools can integrate sc- and bulk RNAseq data, focusing on deconvoluting bulk RNAseq data from heterogeneous tissue to account for
differences in tissue composition90,340,341. These methods estimate and control for cell type
abundance but do not identify cell type-specific expression signatures in bulk datasets.
Analytical strategies that identify cellular gene expression signatures in bulk RNAseq data allow
for robust cell type-specific differential expression analysis and complex network analysis that is
currently not feasible in scRNA-seq data.
In chapter 3 we characterized gene expression in β-cells from obese SM/J mice, who
spontaneously transition from hyperglycemic to normoglycemic with improved β-cell function
between 20 and 30 weeks of age342,343. Several groups have proposed the existence of
functionally distinct β-cell subpopulations24,25,45,356, but their existence and relevance to insulin
homeostasis remain controversial. We identified 4 β-cell populations, Beta 1-4, across
hyperglycemic-obese, normoglycemic-obese, and normoglycemic-lean mice. While the
functional roles assigned to each population are based on gene enrichment analysis and open to
interpretation, the relative proportion of each population changes in conjunction with islet
function across cohorts, suggesting a functional relevance to overall β-cell population structure.
Beta 1 cells appear to be primed for insulin release, but not to perform glucose-stimulated
insulin secretion. Farack et al356 identified a subpopulation of “extreme” β-cells that specialize in
basal insulin secretion, with high insulin expression and low mature insulin content. The Beta 1
cells we identified are similar to “extreme” β-cells based on their mature profile, potentially
limited glucose response, and abundance in diabetic obese mice. Beta 2 cells are enriched for
response to oxygen levels, pyruvate metabolism, and nucleotide phosphorylation, each
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associated with protection from hypoxia362,363. Several groups have identified a subset of heavily
vascularized islets that have elevated oxygen consumption and superior GSIS at the cost of
susceptibility to hypoxia. We suspect Beta 2 cells represent a highly functional β-cell population
that confer protection against hypoxia154,156.Beta 3 cells overexpress plasma membrane
components, including several claudin family members, and ribosome components. Polarity in βcells serves as both a driver and a characteristic of mature, highly functional β-cells43,45,365.
Cldn4, Cldn3, and Cldn7 are all upregulated in Beta 3 cells and associated with mature β-cell
function366. From this we conclude that Beta 3 cells represent a polarized and mature β-cell
population. Terms associated with Beta 4 cells include response to stress and response to
topologically incorrect protein. Several groups have identified β-cell subpopulations based on a
stress response signature91,92,371, which have coalesced into a theory about stress response
cycling, where β-cells go through periods of UPR activation and low insulin production to clear
misfolded proteins21,259. Interestingly, 20wk low-fat mice have a similar proportion of stress
response cycling cells compared to other groups (~7%), however this population is significantly
smaller in high-fat males, suggesting that stress response cycling may be suppressed by obesity.
We developed a technique to integrate single cell data with bulk RNA-seq data to assess β-cellspecific differential expression. While the list of genes identified as β-cell-specific is only 316
genes, sub-setting the bulk RNA-seq data by β-cell-specific genes provided a small but highlyfocused search space to identify genes that influence β-cell function in hyperglycemic-obesity,
normoglycemic-obesity, and healthy mice. We identified Pdyn as a novel candidate gene
associated with improved glycemic control in males. While Pdyn’s role in β-cell function is
unknown, many opioids modulate insulin section391. Pdyn is over expressed in Beta 2 cells,
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which are increased in normoglycemic-obese mice, and may link improved β-cell function with
hypoxia response, as Pdyn provides protection from hypoxia in lung and neuronal tissue378,379.
Weighted gene co-expression network analysis (WGCNA) identified β-cell-specific
modules that correlate with phenotypes. The blue module is highly expressed in 20wk high-fat
males, strongly correlating with blood glucose concentration, and enriched with fatty acid
metabolism genes, which are heavily implicated in obesity and diabetes. Since fatty acid
metabolism can stimulate insulin release, it is possible that prolonged activation of this network
promotes elevated basal insulin secretion but inhibits GSIS. Expression of this network may be
related to the abundance of Beta 1 cells in 20k high-fat males, which are geared toward basal
insulin release. The brown module is highly expressed in lean mice and negatively correlates
with serum insulin levels and enriched for genes associated with β-cell physiology. This network
is suppressed in 20wk high-fat males, who have dysfunctional β-cells. We homed in on
Fam151a, a gene highly connected within the network, that independently correlates with serum
insulin levels. Fam151a is both differentially expressed and differentially connected within the
brown module between 20wk high-fat and 20wk low-fat mice, suggesting an important role
within the network and a potential link between serum insulin levels and β-cell function.
We explored if subpopulation composition contributes to differential expression of Pdyn
and Fam151a. Total Pdyn expression increased across all β-cells between 20 and 30wk high-fat
fed males, in agreement with the bulk RNA-seq data. Pdyn is overexpressed in Beta 2 cells,
which increase in proportion between 20 and 30 weeks in high-fat mice, suggesting differential
expression of Pdyn is driven by a change in subpopulation proportions. Likewise, total Fam151a
increased across all β-cells between 20wk high and low-fat males, in agreement with the bulk
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RNA-seq data. However, Fam151a is strongly overexpressed in Beta 1 cells, which are most
abundant in 20wk high-fat males. To explore this discrepancy, we performed differential
expression analysis in Beta 1 cells between 20wk high and 20wk low-fat males and found
Fam151a expression is significantly higher in 20wk low-fat male Beta 1 cells. Thus, while the
proportion of Beta 1 cells is lower in 20wk low-fat mice, the expression of Fam151a is
significantly increased in their Beta 1 cells.
In conclusion, obese SM/J mice experience improved beta cell function, characterized by
enhanced GSIS, decreased basal insulin secretion, and increased islet insulin content. Underlying
this improvement is a decrease in β-cells associated with basal insulin secretion, and an increase
β-cells associated with hypoxia response. Concurrently, obese SM/J mice decrease expression of
a gene network associated with fatty acid metabolism. Expression of key genes, including Pdyn
and Fam151a, provide strong candidates for exploring differential gene expression between and
within β-cell subpopulations, and how changes in subpopulation structure influence glycemic
control in obesity.
4.2 Future Directions
My thesis work characterized how obese SM/J β-cells change at the morphological,
functional, and transcriptional level. I established that improved β-cell function underlies the
restoration of glycemic control and identified genetic pathways associated with the
hyperglycemic-obese state. While other strains, including LG/J and C57Bl/J6, do not improve
glycemic control with age on a high fat diet, this phenomenon has not been rigorously assessed
in most inbred mouse strains. Performing this experiment on other inbred strains, particularly
those that are susceptible to diet-induced obesity, would reveal if reestablishing glycemic control
97

is truly unique to SM/J mice. A genomic analysis between strains would reveal the genetic
variants that are unique to the SM/J strain, providing candidates that contribute to reestablishing
glycemic control in obesity. This would pave the way for identifying the genetic mechanisms
underlying the resolution of hyperglycemia in SM/J mice, providing candidate genes and
pathways.
The obese SM/J mouse model could be explored in greater depth to characterize the
physiological changes underlying the reestablished glycemic control. Insulin production and
insulin sensitivity are tightly intertwined. While insulin tolerance tests provide a snapshot of
insulin sensitivity, they do not provide a dynamic perspective on the glucose-insulin axis. A
hyperglycemic clamp would assess insulin secretion in vivo by measuring insulin levels when
hyperglycemia is induced by continuous glucose infusion. This would confirm if the
improvement in β-cell function is maintained outside of cultured conditions. Likewise,
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hyperinsulinemic-euglycemic clamp would assess insulin sensitivity in real time. By infusing a
constant level of insulin while infusing variable levels of glucose to maintain equilibrium, true
insulin sensitivity could be assessed. This would reveal the degree to which obese SM/J mice
improve insulin sensitivity over time. Similarly, a time course experiment could reveal the
precise order of events, addressing if improved insulin sensitivity precedes the increase in insulin
production, or vise versa. Examining insulin sensitivity and insulin levels every two weeks over
the 20–30 week range would establish if the improved beta cell function can be attributed to
improvement in insulin sensitivity of metabolic tissues (extrinsic factors) or improved insulin
secretion (intrinsic factors).
Performing islet transplants on obese SM/J mice would also provide insight into the
nature of the improved β-cell function. After treatment, ablation of existing β-cells using STZ or
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a genetic knockout can address if an islet removed from 30wk high fat mice is sufficient to
reestablish glycemic control in 20wk high fat mice. Conversely, transplant experiments can
address if islets from 20wk high fat mice spontaneously improve when transplanted into 30wk
mice, or will if render the mice diabetic. Further, we can ask if islets from 20wk high fat mice
render lean, normoglycemic mice diabetic. If islets from 30wk obese mice improve glycemic
control in younger obese mice, then we can conclude that the improved β-cell function is
intrinsic, and not primarily driven by the islet microenvironment. Likewise, if islets transplanted
from hyperglycemic obese mice improve in 30wk obese mice, we can conclude that the
improvement in β-cell function can be attributed to decreased glycemic stress, suggesting the
improvement is driven by extrinsic factors. If the improvement is driven by extrinsic factors,
focus should shift to other metabolic tissues in the obese SM/J mouse.
Using

immunohistochemistry

to

stain

pancreatic

sections

for

subpopulation

overexpressed genes may verify the existence of the subpopulations at the protein level. Other
gene quantification techniques, such as seqFISH, can confirm differential expression between
subpopulations. If the β-cell subpopulations can be confirmed using imaging techniques, the
effects of genetic knockouts and islet transplantation on subtype composition could be assessed,
helping confirm or reject a role for subpopulation structure in the resolution of hyperglycemia.
Topographical analysis would assess if β-cell subpopulations localize to the islet core or
periphery, or are in proximity to neurons, blood vessels, or other islet cell types, providing
insight into how microenvironment may contribute to the improved β-cell function. If there are
meaningful differences in protein level among subpopulations, cell sorting would allow for
subpopulations to be isolated and reaggregated for analysis, including functional assessment and
gene expression profiling.
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Generating β-cell-specific knockouts of Pdyn and Fam151a in the SM/J genetic
background would allow for examination of each gene in the context of improved glycemic
control in obesity. I hypothesize that ablation of Pdyn will decrease glucose-stimulated insulin
secretion in vivo due to decreased vasodilation but will not affect insulin secretion ex vivo.
Further, I hypothesize treatment with a fatty acid oxidation inhibitor may improve insulin
secretion in 20wk obese islets, including improving GSIS and decreasing basal insulin secretion.
The effects of fatty acid oxidation inhibitor treatment in vivo will be difficult to untangle among
the changes associated with inhibited fatty acid metabolism in other tissues, but it would be
interesting to see if this could alter the proportion of basal insulin secreting β-cells. These
experiments would confirm the importance of the gene expression changes seen in obese SM/J βcells and would warrant exploration in human β-cell models.
The data integration strategy developed here can be applied to other cell types, including
α-cells. Dysfunction of α-cells has been associated with diabetes and obesity and may also
provide potential avenues for treatment. Identification of α-cell-specific genes would allow for
similar assessment of differential expression and genetic networks associated with the hyper- and
normoglycemic obese states. Although analyzing α-cells was outside the scope of this thesis, I
hypothesize α-cell function and gene expression changes during the resolution of hyperglycemia,
and further analysis is likely to uncover candidate genes associated with improved glycemic
control. This data integration strategy could also be applied to healthy and diabetic human islet
datasets, as bulk islet RNA-seq data is in much greater abundance than β-cell scRNA-seq data.
Knockdowns of candidate genes could be performed in human iPSC’s to assess how the gene
contributes to differentiation into a β-cell-like cells, which could improve the efficiency or
function of generating β-cells in vitro.
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